<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Bull World Health Organ</journal-id><journal-id journal-id-type="iso-abbrev">Bull. World Health Organ</journal-id><journal-id journal-id-type="publisher-id">BLT</journal-id><journal-title-group><journal-title>Bulletin of the World Health Organization</journal-title></journal-title-group><issn pub-type="ppub">0042-9686</issn><issn pub-type="epub">1564-0604</issn><publisher><publisher-name>World Health Organization</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25558105</article-id><article-id pub-id-type="pmc">4271680</article-id><article-id pub-id-type="publisher-id">BLT.14.138149</article-id><article-id pub-id-type="doi">10.2471/BLT.14.138149</article-id><article-categories><subj-group subj-group-type="heading"><subject>Systematic Reviews</subject></subj-group></article-categories><title-group><article-title>Association between antiretroviral therapy adherence and employment status: systematic review and meta-analysis</article-title><trans-title-group xml:lang="fr"><trans-title xml:lang="fr">Lien entre le suivi de la th&#x000e9;rapie antir&#x000e9;trovirale et le statut professionnel: revue syst&#x000e9;matique et m&#x000e9;ta-analyse</trans-title></trans-title-group><trans-title-group xml:lang="es"><trans-title xml:lang="es">La asociaci&#x000f3;n entre la adherencia a la terapia antirretroviral y la situaci&#x000f3;n laboral: examen sistem&#x000e1;tico y metaan&#x000e1;lisis</trans-title></trans-title-group><trans-title-group xml:lang="ar"><trans-title xml:lang="ar">&#x00627;&#x00644;&#x00627;&#x00631;&#x0062a;&#x00628;&#x00627;&#x00637; &#x00628;&#x0064a;&#x00646; &#x00627;&#x00644;&#x00627;&#x00644;&#x0062a;&#x00632;&#x00627;&#x00645; &#x00628;&#x00627;&#x00644;&#x00639;&#x00644;&#x00627;&#x0062c; &#x00628;&#x00645;&#x00636;&#x00627;&#x0062f;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00641;&#x0064a;&#x00631;&#x00648;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00642;&#x00647;&#x00642;&#x00631;&#x0064a;&#x00629; &#x00648;&#x0062d;&#x00627;&#x00644;&#x00629; &#x00627;&#x00644;&#x0062a;&#x00648;&#x00638;&#x0064a;&#x00641;: &#x00627;&#x00633;&#x0062a;&#x00639;&#x00631;&#x00627;&#x00636; &#x00645;&#x00646;&#x00647;&#x0062c;&#x0064a; &#x00648;&#x0062a;&#x0062d;&#x00644;&#x0064a;&#x00644; &#x00648;&#x00635;&#x00641;&#x0064a; </trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title xml:lang="zh">&#x06297;&#x09006;&#x08f6c;&#x05f55;&#x075c5;&#x06bd2;&#x07597;&#x06cd5;&#x07684;&#x0575a;&#x06301;&#x0548c;&#x05c31;&#x04e1a;&#x072b6;&#x051b5;&#x04e4b;&#x095f4;&#x07684;&#x05173;&#x08054;&#x0ff1a;&#x07cfb;&#x07edf;&#x056de;&#x0987e;&#x0548c;&#x05143;&#x05206;&#x06790;</trans-title></trans-title-group><trans-title-group xml:lang="ru"><trans-title xml:lang="ru">&#x00421;&#x00432;&#x0044f;&#x00437;&#x0044c; &#x0043c;&#x00435;&#x00436;&#x00434;&#x00443; &#x00441;&#x0043e;&#x00431;&#x0043b;&#x0044e;&#x00434;&#x00435;&#x0043d;&#x00438;&#x00435;&#x0043c; &#x00440;&#x00435;&#x00436;&#x00438;&#x0043c;&#x00430; &#x00430;&#x0043d;&#x00442;&#x00438;&#x00440;&#x00435;&#x00442;&#x00440;&#x0043e;&#x00432;&#x00438;&#x00440;&#x00443;&#x00441;&#x0043d;&#x0043e;&#x00439; &#x00442;&#x00435;&#x00440;&#x00430;&#x0043f;&#x00438;&#x00438; &#x00438; &#x00441;&#x00442;&#x00430;&#x00442;&#x00443;&#x00441;&#x0043e;&#x0043c; &#x00437;&#x00430;&#x0043d;&#x0044f;&#x00442;&#x0043e;&#x00441;&#x00442;&#x00438;: &#x00441;&#x00438;&#x00441;&#x00442;&#x00435;&#x0043c;&#x00430;&#x00442;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x00438;&#x00439; &#x0043e;&#x00431;&#x00437;&#x0043e;&#x00440; &#x00438; &#x0043c;&#x00435;&#x00442;&#x00430;-&#x00430;&#x0043d;&#x00430;&#x0043b;&#x00438;&#x00437;</trans-title></trans-title-group><alt-title alt-title-type="author-running-head">Jean B Nachega et al.</alt-title><alt-title alt-title-type="title-running-head">Antiretroviral therapy adherence and employment</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Nachega</surname><given-names>Jean B</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Uthman</surname><given-names>Olalekan A</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Peltzer</surname><given-names>Karl</given-names></name><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Richardson</surname><given-names>Lindsey A</given-names></name><xref ref-type="aff" rid="aff4"><sup>d</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mills</surname><given-names>Edward J</given-names></name><xref ref-type="aff" rid="aff5"><sup>e</sup></xref></contrib><contrib contrib-type="author"><name><surname>Amekudzi</surname><given-names>Kofi</given-names></name><xref ref-type="aff" rid="aff6"><sup>f</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ou&#x000e9;draogo</surname><given-names>Alice</given-names></name><xref ref-type="aff" rid="aff6"><sup>f</sup></xref></contrib><aff id="aff1"><label>a</label>Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, 503 Parran Hall, 130 DeSoto Street, Pittsburgh, PA 15261, United States of America (USA).</aff><aff id="aff2"><label>b</label>Warwick Centre for Applied Health Research and Delivery, University of Warwick, Coventry, <country>England</country>.</aff><aff id="aff3"><label>c</label>Department of Psychology, University of Limpopo, Turfloop, <country>South Africa</country>.</aff><aff id="aff4"><label>d</label>Department of Sociology, University of British Columbia, Vancouver, <country>Canada</country>.</aff><aff id="aff5"><label>e</label>Stanford Prevention Research Center, Stanford University, Stanford, <country>USA</country>.</aff><aff id="aff6"><label>f</label>HIV/AIDS and the World of Work Branch (ILOAIDS), International Labour Organization, Geneva, <country>Switzerland</country>.</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to Jean B Nachega (email: <email xlink:href="jbn16@pitt.edu">jbn16@pitt.edu</email>).</corresp></author-notes><pub-date pub-type="ppub"><day>01</day><month>1</month><year>2015</year></pub-date><pub-date pub-type="epub"><day>30</day><month>10</month><year>2014</year></pub-date><volume>93</volume><issue>1</issue><fpage>29</fpage><lpage>41</lpage><history><date date-type="received"><day>04</day><month>3</month><year>2014</year></date><date date-type="rev-recd"><day>21</day><month>9</month><year>2014</year></date><date date-type="accepted"><day>01</day><month>10</month><year>2014</year></date></history><permissions><copyright-statement>(c) 2015 The authors; licensee World Health Organization.</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/igo/legalcode">http://creativecommons.org/licenses/by/3.0/igo/legalcode</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.</license-p></license></permissions><abstract><title>Abstract</title><sec><title>Objective</title><p>To assess the association between the employment status of human immunodeficiency virus (HIV)-infected individuals and adherence to antiretroviral therapy (ART).</p></sec><sec><title>Methods</title><p>We searched the Medline, Embase and Cochrane Central Register of Controlled Trials databases for studies reporting ART adherence and employment status published between January 1980 and September 2014. Information from a wide range of other sources, including the grey literature, was also analysed. Two independent reviewers extracted data on treatment adherence and study characteristics. Study data on the association between being employed and adhering to ART were pooled using a random-effects model. Between-study heterogeneity and sources of bias were evaluated.</p></sec><sec><title>Findings</title><p>The meta-analysis included 28 studies published between 1996 and 2014 that together involved 8743 HIV-infected individuals from 14 countries. The overall pooled odds ratio (OR) for the association between being employed and adhering to ART was 1.27 (95% confidence interval, CI: 1.04&#x02013;1.55). The association was significant for studies from low-income countries (OR:&#x02009;1.85, 95% CI: 1.58&#x02013;2.18) and high-income countries (OR:&#x02009;1.33, 95% CI: 1.02&#x02013;1.74) but not middle-income countries (OR:&#x02009;0.94, 95% CI: 0.62&#x02013;1.42). In addition, studies published after 2011 and larger studies showed less association between employment and adherence than earlier and small studies, respectively.</p></sec><sec><title>Conclusion</title><p>Employed HIV-infected individuals, particularly those in low- and high-income countries, were more likely to adhere to ART than unemployed individuals. Further research is needed on the mechanisms by which employment and ART adherence affect each other and on whether employment-creation interventions can positively influence ART adherence, HIV disease progression and quality of life.</p></sec></abstract><trans-abstract xml:lang="fr"><title>R&#x000e9;sum&#x000e9;</title><sec><title>Objectif</title><p>&#x000c9;valuer le lien entre le statut professionnel des personnes infect&#x000e9;es par le virus de l'immunod&#x000e9;ficience humaine (VIH) et le suivi de la th&#x000e9;rapie antir&#x000e9;trovirale (TAR).</p></sec><sec><title>M&#x000e9;thodes</title><p>Nous avons effectu&#x000e9; des recherches dans les bases de donn&#x000e9;es de Medline, d'Embase et du registre central de Cochrane des essais contr&#x000f4;l&#x000e9;s (<italic>Cochrane Central Register of Controlled Trials</italic>) pour trouver les &#x000e9;tudes relatives au suivi de la TAR et aux statuts professionnels qui ont &#x000e9;t&#x000e9; publi&#x000e9;es entre janvier&#x000a0;1980 et septembre&#x000a0;2014. Des informations provenant d'un large &#x000e9;ventail de sources alternatives, y compris la litt&#x000e9;rature grise, ont &#x000e9;galement &#x000e9;t&#x000e9; analys&#x000e9;es. Deux examinateurs ind&#x000e9;pendants ont extrait les donn&#x000e9;es sur le suivi du traitement et les caract&#x000e9;ristiques de l'&#x000e9;tude. Les donn&#x000e9;es de l'&#x000e9;tude sur le lien existant entre le fait d'avoir un emploi et le suivi de la TAR ont &#x000e9;t&#x000e9; regroup&#x000e9;es en utilisant un mod&#x000e8;le &#x000e0; effets al&#x000e9;atoires. L'h&#x000e9;t&#x000e9;rog&#x000e9;n&#x000e9;it&#x000e9; entre les &#x000e9;tudes et les sources de biais ont &#x000e9;t&#x000e9; &#x000e9;valu&#x000e9;es.</p></sec><sec><title>R&#x000e9;sultats</title><p>La m&#x000e9;ta-analyse a inclus 28&#x000a0;&#x000e9;tudes publi&#x000e9;es entre&#x000a0;1996&#x000a0;et&#x000a0;2014, qui, ensemble, ont impliqu&#x000e9; 8743&#x000a0;personnes infect&#x000e9;es par le VIH dans 14&#x000a0;pays. Le rapport des cotes (RC) regroup&#x000e9; global pour le lien entre le fait d'avoir un emploi et le suivi de la TAR &#x000e9;tait de&#x000a0;1,27 (intervalle de confiance &#x000e0;&#x000a0;95%, IC: 1,04&#x02013;1,55). Ce lien &#x000e9;tait significatif pour les &#x000e9;tudes dans les pays &#x000e0; revenu faible (RC:&#x02009;1,85; IC&#x000a0;95%: 1,58&#x02013;2,18) et dans les pays &#x000e0; revenu &#x000e9;lev&#x000e9; (RC:&#x02009;1,33; IC&#x000a0;95%: 1,02&#x02013;1,74) mais il ne l'&#x000e9;tait pas dans les pays &#x000e0; revenu interm&#x000e9;diaire (RC:&#x02009;0,94; IC&#x000a0;95%: 0,62&#x02013;1,42). En outre, les &#x000e9;tudes publi&#x000e9;es apr&#x000e8;s&#x000a0;2011 et les &#x000e9;tudes plus vastes ont montr&#x000e9; un lien moins fort entre le statut professionnel et le suivi th&#x000e9;rapeutique que dans les &#x000e9;tudes pr&#x000e9;c&#x000e9;dentes et les &#x000e9;tudes plus restreintes, respectivement.</p></sec><sec><title>Conclusion</title><p>Les personnes infect&#x000e9;es par le VIH et ayant un emploi, en particulier dans les pays &#x000e0; revenu faible et les pays &#x000e0; revenu &#x000e9;lev&#x000e9;, &#x000e9;taient plus susceptibles de suivre la TAR que les personnes sans emploi. Des recherches plus approfondies sont n&#x000e9;cessaires pour &#x000e9;tudier les m&#x000e9;canismes par lesquels le fait d'avoir un emploi et le fait de suivre la TAR s'affectent mutuellement et pour savoir si les interventions favorisant la cr&#x000e9;ation d'emplois peuvent influencer positivement le suivi de la TAR, la progression de la maladie due au VIH et la qualit&#x000e9; de vie.</p></sec></trans-abstract><trans-abstract xml:lang="es"><title>Resumen</title><sec><title>Objetivo</title><p>Evaluar la relaci&#x000f3;n entre la situaci&#x000f3;n laboral de personas infectadas por el virus de la inmunodeficiencia humana (VIH) y la adherencia a la terapia antirretroviral (TAR).</p></sec><sec><title>M&#x000e9;todos</title><p>Se realizaron b&#x000fa;squedas de estudios publicados entre enero de 1980 y septiembre de 2014 que informaran acerca de la adherencia a la TAR y la situaci&#x000f3;n laboral en las bases de datos Medline, Embase y el Registro Cochrane Central de Ensayos Controlados. Tambi&#x000e9;n se analiz&#x000f3; la informaci&#x000f3;n de una amplia gama de fuentes, entre ellas, la literatura gris. Dos revisores independientes extrajeron los datos sobre la adherencia al tratamiento y las caracter&#x000ed;sticas del estudio. Los datos de los estudios sobre la asociaci&#x000f3;n entre el empleo y la adherencia a la TAR se agruparon por medio de un modelo de efectos aleatorios y se evalu&#x000f3; la heterogeneidad entre los estudios y las fuentes de sesgo.</p></sec><sec><title>Resultados</title><p>El metan&#x000e1;lisis incluy&#x000f3; 28 estudios publicados entre 1996 y el 2014 que incluyeron 8743 individuos infectados por el VIH provenientes de 14 pa&#x000ed;ses. La raz&#x000f3;n de posibilidades agrupada general (OR) para la asociaci&#x000f3;n entre estar empleado y la adherencia a la TAR fue 1,27 (intervalo de confianza del 95%, IC: 1,04&#x02013;1,55). La asociaci&#x000f3;n fue significativa en los estudios en pa&#x000ed;ses con ingresos bajos (OR:&#x02009;1,85, IC del 95%: 1,58&#x02013;2,18) ycon ingresos altos (OR:&#x02009;1,33, IC del 95%: 1,02&#x02013;1,74), pero no en los pa&#x000ed;ses con ingresos medios (OR:&#x02009;0,94, IC del 95%: 0,62&#x02013;1,42). Adem&#x000e1;s, los estudios publicados despu&#x000e9;s de 2011 y los de mayor tama&#x000f1;o mostraron una relaci&#x000f3;n menor entre el empleo y la adherencia que, respectivamente, los estudios anteriores y m&#x000e1;s peque&#x000f1;os. </p></sec><sec><title>Conclusi&#x000f3;n</title><p>Las personas infectadas por el VIH con un empleo, en particular en los pa&#x000ed;ses con ingresos bajos y altos, ten&#x000ed;an m&#x000e1;s probabilidades de adherirse a la TAR que las personas desempleadas. Se necesitan investigaciones adicionales sobre los mecanismos por los que el empleo y la adherencia a la TAR se influyen mutuamente y sobre si las intervenciones de creaci&#x000f3;n de empleo pueden influir positivamente la adherencia a la TAR, la progresi&#x000f3;n de la enfermedad del VIH y la calidad de vida. </p></sec></trans-abstract><trans-abstract xml:lang="ar"><title>&#x00645;&#x00644;&#x0062e;&#x00635; </title><sec><title>&#x00627;&#x00644;&#x0063a;&#x00631;&#x00636; </title><p>&#x0062a;&#x00642;&#x0064a;&#x0064a;&#x00645; &#x00627;&#x00644;&#x00627;&#x00631;&#x0062a;&#x00628;&#x00627;&#x00637; &#x00628;&#x0064a;&#x00646; &#x0062d;&#x00627;&#x00644;&#x00629; &#x00627;&#x00644;&#x0062a;&#x00648;&#x00638;&#x0064a;&#x00641; &#x00644;&#x0062f;&#x00649; &#x00627;&#x00644;&#x00623;&#x00634;&#x0062e;&#x00627;&#x00635; &#x00627;&#x00644;&#x00645;&#x00635;&#x00627;&#x00628;&#x0064a;&#x00646; &#x00628;&#x00639;&#x0062f;&#x00648;&#x00649; &#x00641;&#x0064a;&#x00631;&#x00648;&#x00633; &#x00627;&#x00644;&#x00639;&#x00648;&#x00632; &#x00627;&#x00644;&#x00645;&#x00646;&#x00627;&#x00639;&#x0064a; &#x00627;&#x00644;&#x00628;&#x00634;&#x00631;&#x0064a; &#x00648;&#x00627;&#x00644;&#x00627;&#x00644;&#x0062a;&#x00632;&#x00627;&#x00645; &#x00628;&#x00627;&#x00644;&#x00639;&#x00644;&#x00627;&#x0062c; &#x00628;&#x00645;&#x00636;&#x00627;&#x0062f;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00641;&#x0064a;&#x00631;&#x00648;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00642;&#x00647;&#x00642;&#x00631;&#x0064a;&#x00629;. </p></sec><sec><title>&#x00627;&#x00644;&#x00637;&#x00631;&#x0064a;&#x00642;&#x00629; </title><p>&#x00623;&#x0062c;&#x00631;&#x0064a;&#x00646;&#x00627; &#x00628;&#x0062d;&#x0062b;&#x00627;&#x0064b; &#x00641;&#x0064a; &#x00642;&#x00648;&#x00627;&#x00639;&#x0062f; &#x00628;&#x0064a;&#x00627;&#x00646;&#x00627;&#x0062a; Medline &#x00648;Embase &#x00648;&#x00633;&#x0062c;&#x00644; &#x00643;&#x00648;&#x00643;&#x00631;&#x0064a;&#x00646; &#x00627;&#x00644;&#x00645;&#x00631;&#x00643;&#x00632;&#x0064a; &#x00644;&#x00644;&#x0062a;&#x0062c;&#x00627;&#x00631;&#x00628; &#x00627;&#x00644;&#x0062e;&#x00627;&#x00636;&#x00639;&#x00629; &#x00644;&#x00644;&#x00645;&#x00631;&#x00627;&#x00642;&#x00628;&#x00629; &#x00645;&#x00646; &#x00623;&#x0062c;&#x00644; &#x00645;&#x00639;&#x00631;&#x00641;&#x00629; &#x00627;&#x00644;&#x0062f;&#x00631;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062a;&#x0064a; &#x00623;&#x00628;&#x00644;&#x0063a;&#x0062a; &#x00639;&#x00646; &#x00627;&#x00644;&#x00627;&#x00644;&#x0062a;&#x00632;&#x00627;&#x00645; &#x00628;&#x00627;&#x00644;&#x00639;&#x00644;&#x00627;&#x0062c; &#x00628;&#x00645;&#x00636;&#x00627;&#x0062f;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00641;&#x0064a;&#x00631;&#x00648;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00642;&#x00647;&#x00642;&#x00631;&#x0064a;&#x00629; &#x00648;&#x0062d;&#x00627;&#x00644;&#x00629; &#x00627;&#x00644;&#x0062a;&#x00648;&#x00638;&#x0064a;&#x00641; &#x00648;&#x0062a;&#x00645; &#x00646;&#x00634;&#x00631;&#x00647;&#x00627; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00641;&#x0062a;&#x00631;&#x00629; &#x00645;&#x00646; &#x00643;&#x00627;&#x00646;&#x00648;&#x00646; &#x00627;&#x00644;&#x0062b;&#x00627;&#x00646;&#x0064a;/&#x0064a;&#x00646;&#x00627;&#x0064a;&#x00631; 1980 &#x00625;&#x00644;&#x00649; &#x00623;&#x0064a;&#x00644;&#x00648;&#x00644;/&#x00633;&#x00628;&#x0062a;&#x00645;&#x00628;&#x00631; 2014. &#x00648;&#x0062a;&#x00645; &#x00643;&#x00630;&#x00644;&#x00643; &#x0062a;&#x0062d;&#x00644;&#x0064a;&#x00644; &#x00627;&#x00644;&#x00645;&#x00639;&#x00644;&#x00648;&#x00645;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00645;&#x00633;&#x0062a;&#x00645;&#x0062f;&#x00629; &#x00645;&#x00646; &#x00646;&#x00637;&#x00627;&#x00642; &#x00648;&#x00627;&#x00633;&#x00639; &#x00645;&#x00646; &#x00627;&#x00644;&#x00645;&#x00635;&#x00627;&#x0062f;&#x00631; &#x00627;&#x00644;&#x00623;&#x0062e;&#x00631;&#x00649;&#x0060c; &#x00628;&#x00645;&#x00627; &#x00641;&#x0064a; &#x00630;&#x00644;&#x00643; &#x00627;&#x00644;&#x00623;&#x00628;&#x0062d;&#x00627;&#x0062b; &#x0063a;&#x0064a;&#x00631; &#x00627;&#x00644;&#x00631;&#x00633;&#x00645;&#x0064a;&#x00629;. &#x00648;&#x00627;&#x00633;&#x0062a;&#x0062e;&#x00644;&#x00635; &#x00645;&#x00631;&#x00627;&#x0062c;&#x00639;&#x00627;&#x00646; &#x00645;&#x00633;&#x0062a;&#x00642;&#x00644;&#x00627;&#x00646; &#x00627;&#x00644;&#x00628;&#x0064a;&#x00627;&#x00646;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062e;&#x00627;&#x00635;&#x00629; &#x00628;&#x00627;&#x00644;&#x00627;&#x00644;&#x0062a;&#x00632;&#x00627;&#x00645; &#x00628;&#x00627;&#x00644;&#x00639;&#x00644;&#x00627;&#x0062c; &#x00648;&#x0062e;&#x00635;&#x00627;&#x00626;&#x00635; &#x00627;&#x00644;&#x0062f;&#x00631;&#x00627;&#x00633;&#x00629;. &#x00648;&#x0062a;&#x00645; &#x0062a;&#x0062c;&#x00645;&#x0064a;&#x00639; &#x00628;&#x0064a;&#x00627;&#x00646;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062f;&#x00631;&#x00627;&#x00633;&#x00629; &#x00627;&#x00644;&#x00645;&#x00639;&#x00646;&#x0064a;&#x00629; &#x00628;&#x00627;&#x00644;&#x00627;&#x00631;&#x0062a;&#x00628;&#x00627;&#x00637; &#x00628;&#x0064a;&#x00646; &#x00627;&#x00644;&#x0062a;&#x00648;&#x00638;&#x0064a;&#x00641; &#x00648;&#x00627;&#x00644;&#x00627;&#x00644;&#x0062a;&#x00632;&#x00627;&#x00645; &#x00628;&#x00627;&#x00644;&#x00639;&#x00644;&#x00627;&#x0062c; &#x00628;&#x00645;&#x00636;&#x00627;&#x0062f;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00641;&#x0064a;&#x00631;&#x00648;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00642;&#x00647;&#x00642;&#x00631;&#x0064a;&#x00629; &#x00628;&#x00627;&#x00633;&#x0062a;&#x0062e;&#x0062f;&#x00627;&#x00645; &#x00646;&#x00645;&#x00648;&#x00630;&#x0062c; &#x00627;&#x00644;&#x0062a;&#x00623;&#x0062b;&#x0064a;&#x00631;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00639;&#x00634;&#x00648;&#x00627;&#x00626;&#x0064a;&#x00629;. &#x00648;&#x0062a;&#x00645; &#x0062a;&#x00642;&#x0062f;&#x0064a;&#x00631; &#x00627;&#x00644;&#x0062a;&#x0063a;&#x00627;&#x0064a;&#x00631;&#x0064a;&#x00629; &#x00628;&#x0064a;&#x00646; &#x00627;&#x00644;&#x0062f;&#x00631;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00648;&#x00645;&#x00635;&#x00627;&#x0062f;&#x00631; &#x00627;&#x00644;&#x0062a;&#x0062d;&#x0064a;&#x00632;. </p></sec><sec><title>&#x00627;&#x00644;&#x00646;&#x0062a;&#x00627;&#x00626;&#x0062c; </title><p>&#x0062a;&#x00636;&#x00645;&#x00646; &#x00627;&#x00644;&#x0062a;&#x0062d;&#x00644;&#x0064a;&#x00644; &#x00627;&#x00644;&#x00648;&#x00635;&#x00641;&#x0064a; 28 &#x0062f;&#x00631;&#x00627;&#x00633;&#x00629; &#x0062a;&#x00645; &#x00646;&#x00634;&#x00631;&#x00647;&#x00627; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00641;&#x0062a;&#x00631;&#x00629; &#x00645;&#x00646; 1996 &#x00625;&#x00644;&#x00649; 2014 &#x00648;&#x00627;&#x00644;&#x0062a;&#x0064a; &#x00634;&#x00645;&#x00644;&#x0062a; &#x00645;&#x00639;&#x00627;&#x0064b; 8743 &#x00634;&#x0062e;&#x00635;&#x00627;&#x0064b; &#x00645;&#x00635;&#x00627;&#x00628;&#x00627;&#x0064b; &#x00628;&#x00639;&#x0062f;&#x00648;&#x00649; &#x00641;&#x0064a;&#x00631;&#x00648;&#x00633; &#x00627;&#x00644;&#x00639;&#x00648;&#x00632; &#x00627;&#x00644;&#x00645;&#x00646;&#x00627;&#x00639;&#x0064a; &#x00627;&#x00644;&#x00628;&#x00634;&#x00631;&#x0064a; &#x00645;&#x00646; 14 &#x00628;&#x00644;&#x0062f;&#x00627;&#x0064b;. &#x00648;&#x00643;&#x00627;&#x00646;&#x0062a; &#x00646;&#x00633;&#x00628;&#x00629; &#x00627;&#x00644;&#x00627;&#x0062d;&#x0062a;&#x00645;&#x00627;&#x00644; &#x00627;&#x00644;&#x00645;&#x0062c;&#x00645;&#x00639;&#x00629; &#x00644;&#x00644;&#x00627;&#x00631;&#x0062a;&#x00628;&#x00627;&#x00637; &#x00628;&#x0064a;&#x00646; &#x00627;&#x00644;&#x0062a;&#x00648;&#x00638;&#x0064a;&#x00641; &#x00648;&#x00627;&#x00644;&#x00627;&#x00644;&#x0062a;&#x00632;&#x00627;&#x00645; &#x00628;&#x00627;&#x00644;&#x00639;&#x00644;&#x00627;&#x0062c; &#x00628;&#x00645;&#x00636;&#x00627;&#x0062f;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00641;&#x0064a;&#x00631;&#x00648;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00642;&#x00647;&#x00642;&#x00631;&#x0064a;&#x00629; &#x00628;&#x00634;&#x00643;&#x00644; &#x00639;&#x00627;&#x00645; 1.27 (&#x00641;&#x00627;&#x00635;&#x00644; &#x00627;&#x00644;&#x0062b;&#x00642;&#x00629; <styled-content style-type="direction" style="direction:ltr;">95&#x000a0;%</styled-content>&#x0060c; &#x00641;&#x00627;&#x00635;&#x00644; &#x00627;&#x00644;&#x0062b;&#x00642;&#x00629;: &#x00645;&#x00646; 1.04 &#x00625;&#x00644;&#x00649; 1.55). &#x00648;&#x00643;&#x00627;&#x00646; &#x00627;&#x00644;&#x00627;&#x00631;&#x0062a;&#x00628;&#x00627;&#x00637; &#x00643;&#x00628;&#x0064a;&#x00631;&#x00627;&#x0064b; &#x00628;&#x00627;&#x00644;&#x00646;&#x00633;&#x00628;&#x00629; &#x00644;&#x00644;&#x0062f;&#x00631;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00645;&#x00646; &#x00627;&#x00644;&#x00628;&#x00644;&#x0062f;&#x00627;&#x00646; &#x00627;&#x00644;&#x00645;&#x00646;&#x0062e;&#x00641;&#x00636;&#x00629; &#x00627;&#x00644;&#x0062f;&#x0062e;&#x00644; (&#x00646;&#x00633;&#x00628;&#x00629; &#x00627;&#x00644;&#x00627;&#x0062d;&#x0062a;&#x00645;&#x00627;&#x00644;:&#x02009;1.85&#x0060c; &#x00641;&#x00627;&#x00635;&#x00644; &#x00627;&#x00644;&#x0062b;&#x00642;&#x00629;: <styled-content style-type="direction" style="direction:ltr;">95&#x000a0;%</styled-content>&#x0060c; &#x00641;&#x00627;&#x00635;&#x00644; &#x00627;&#x00644;&#x0062b;&#x00642;&#x00629;: &#x00645;&#x00646; 1.58 &#x00625;&#x00644;&#x00649; 2.18) &#x00648;&#x00627;&#x00644;&#x00628;&#x00644;&#x0062f;&#x00627;&#x00646; &#x00627;&#x00644;&#x00645;&#x00631;&#x0062a;&#x00641;&#x00639;&#x00629; &#x00627;&#x00644;&#x0062f;&#x0062e;&#x00644; (&#x00646;&#x00633;&#x00628;&#x00629; &#x00627;&#x00644;&#x00627;&#x0062d;&#x0062a;&#x00645;&#x00627;&#x00644;:&#x02009;1.33&#x0060c; &#x00641;&#x00627;&#x00635;&#x00644; &#x00627;&#x00644;&#x0062b;&#x00642;&#x00629;: <styled-content style-type="direction" style="direction:ltr;">95&#x000a0;%</styled-content>&#x0060c; &#x00641;&#x00627;&#x00635;&#x00644; &#x00627;&#x00644;&#x0062b;&#x00642;&#x00629;: &#x00645;&#x00646; 1.02 &#x00625;&#x00644;&#x00649; 1.74) &#x0062f;&#x00648;&#x00646; &#x00627;&#x00644;&#x00628;&#x00644;&#x0062f;&#x00627;&#x00646; &#x00627;&#x00644;&#x00645;&#x0062a;&#x00648;&#x00633;&#x00637;&#x00629; &#x00627;&#x00644;&#x0062f;&#x0062e;&#x00644; (&#x00646;&#x00633;&#x00628;&#x00629; &#x00627;&#x00644;&#x00627;&#x0062d;&#x0062a;&#x00645;&#x00627;&#x00644;:&#x02009;0.94&#x0060c; &#x00641;&#x00627;&#x00635;&#x00644; &#x00627;&#x00644;&#x0062b;&#x00642;&#x00629;: <styled-content style-type="direction" style="direction:ltr;">95&#x000a0;%</styled-content>&#x0060c; &#x00641;&#x00627;&#x00635;&#x00644; &#x00627;&#x00644;&#x0062b;&#x00642;&#x00629;: &#x00645;&#x00646; 0.62 &#x00625;&#x00644;&#x00649; 1.42). &#x00628;&#x00627;&#x00644;&#x00625;&#x00636;&#x00627;&#x00641;&#x00629; &#x00625;&#x00644;&#x00649; &#x00630;&#x00644;&#x00643;&#x0060c; &#x00623;&#x00648;&#x00636;&#x0062d;&#x0062a; &#x00627;&#x00644;&#x0062f;&#x00631;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062a;&#x0064a; &#x0062a;&#x00645; &#x00646;&#x00634;&#x00631;&#x00647;&#x00627; &#x00628;&#x00639;&#x0062f; &#x00639;&#x00627;&#x00645; 2011 &#x00648;&#x00627;&#x00644;&#x0062f;&#x00631;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00623;&#x00643;&#x00628;&#x00631; &#x00646;&#x00633;&#x00628;&#x00629; &#x00627;&#x00631;&#x0062a;&#x00628;&#x00627;&#x00637; &#x00623;&#x00642;&#x00644; &#x00628;&#x0064a;&#x00646; &#x00627;&#x00644;&#x0062a;&#x00648;&#x00638;&#x0064a;&#x00641; &#x00648;&#x00627;&#x00644;&#x00627;&#x00644;&#x0062a;&#x00632;&#x00627;&#x00645; &#x00639;&#x00646; &#x00627;&#x00644;&#x0062f;&#x00631;&#x00627;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00633;&#x00627;&#x00628;&#x00642;&#x00629; &#x00648;&#x00627;&#x00644;&#x00635;&#x0063a;&#x0064a;&#x00631;&#x00629;&#x0060c; &#x00639;&#x00644;&#x00649; &#x00627;&#x00644;&#x0062a;&#x00648;&#x00627;&#x00644;&#x0064a;. </p></sec><sec><title>&#x00627;&#x00644;&#x00627;&#x00633;&#x0062a;&#x00646;&#x0062a;&#x00627;&#x0062c; </title><p>&#x0064a;&#x00631;&#x0062c;&#x0062d; &#x00627;&#x00644;&#x0062a;&#x00632;&#x00627;&#x00645; &#x00627;&#x00644;&#x00623;&#x00634;&#x0062e;&#x00627;&#x00635; &#x00627;&#x00644;&#x00645;&#x00635;&#x00627;&#x00628;&#x0064a;&#x00646; &#x00628;&#x00639;&#x0062f;&#x00648;&#x00649; &#x00641;&#x0064a;&#x00631;&#x00648;&#x00633; &#x00627;&#x00644;&#x00639;&#x00648;&#x00632; &#x00627;&#x00644;&#x00645;&#x00646;&#x00627;&#x00639;&#x0064a; &#x00627;&#x00644;&#x00628;&#x00634;&#x00631;&#x0064a; &#x00627;&#x00644;&#x00645;&#x00648;&#x00638;&#x00641;&#x0064a;&#x00646;&#x0060c; &#x00644;&#x00627; &#x00633;&#x0064a;&#x00645;&#x00627; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00628;&#x00644;&#x0062f;&#x00627;&#x00646; &#x00627;&#x00644;&#x00645;&#x00646;&#x0062e;&#x00641;&#x00636;&#x00629; &#x00648;&#x00627;&#x00644;&#x00628;&#x00644;&#x0062f;&#x00627;&#x00646; &#x00627;&#x00644;&#x00645;&#x00631;&#x0062a;&#x00641;&#x00639;&#x00629; &#x00627;&#x00644;&#x0062f;&#x0062e;&#x00644;&#x0060c; &#x00628;&#x00627;&#x00644;&#x00639;&#x00644;&#x00627;&#x0062c; &#x00628;&#x00645;&#x00636;&#x00627;&#x0062f;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00641;&#x0064a;&#x00631;&#x00648;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00642;&#x00647;&#x00642;&#x00631;&#x0064a;&#x00629; &#x00639;&#x00646; &#x00627;&#x00644;&#x00623;&#x00634;&#x0062e;&#x00627;&#x00635; &#x00627;&#x00644;&#x00639;&#x00627;&#x00637;&#x00644;&#x0064a;&#x00646;. &#x00648;&#x0064a;&#x0062a;&#x00639;&#x0064a;&#x00646; &#x00625;&#x0062c;&#x00631;&#x00627;&#x00621; &#x00627;&#x00644;&#x00645;&#x00632;&#x0064a;&#x0062f; &#x00645;&#x00646; &#x00627;&#x00644;&#x00623;&#x00628;&#x0062d;&#x00627;&#x0062b; &#x00628;&#x00634;&#x00623;&#x00646; &#x00627;&#x00644;&#x00622;&#x00644;&#x0064a;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062a;&#x0064a; &#x0064a;&#x00624;&#x0062b;&#x00631; &#x00645;&#x00646; &#x0062e;&#x00644;&#x00627;&#x00644;&#x00647;&#x00627; &#x00627;&#x00644;&#x0062a;&#x00648;&#x00638;&#x0064a;&#x00641; &#x00648;&#x00627;&#x00644;&#x00627;&#x00644;&#x0062a;&#x00632;&#x00627;&#x00645; &#x00628;&#x00627;&#x00644;&#x00639;&#x00644;&#x00627;&#x0062c; &#x00628;&#x00645;&#x00636;&#x00627;&#x0062f;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00641;&#x0064a;&#x00631;&#x00648;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00642;&#x00647;&#x00642;&#x00631;&#x0064a;&#x00629; &#x00643;&#x00644; &#x00645;&#x00646;&#x00647;&#x00645;&#x00627; &#x00639;&#x00644;&#x00649; &#x00627;&#x00644;&#x00622;&#x0062e;&#x00631; &#x00648;&#x00628;&#x00634;&#x00623;&#x00646; &#x00645;&#x00627; &#x00625;&#x00630;&#x00627; &#x00643;&#x00627;&#x00646; &#x00628;&#x00625;&#x00645;&#x00643;&#x00627;&#x00646; &#x0062a;&#x0062f;&#x0062e;&#x00644;&#x00627;&#x0062a; &#x00625;&#x0064a;&#x0062c;&#x00627;&#x0062f; &#x00627;&#x00644;&#x0062a;&#x00648;&#x00638;&#x0064a;&#x00641; &#x00623;&#x00646; &#x0062a;&#x00624;&#x0062b;&#x00631; &#x00625;&#x0064a;&#x0062c;&#x00627;&#x00628;&#x0064a;&#x00627;&#x0064b; &#x00639;&#x00644;&#x00649; &#x00627;&#x00644;&#x00627;&#x00644;&#x0062a;&#x00632;&#x00627;&#x00645; &#x00628;&#x00627;&#x00644;&#x00639;&#x00644;&#x00627;&#x0062c; &#x00628;&#x00645;&#x00636;&#x00627;&#x0062f;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00641;&#x0064a;&#x00631;&#x00648;&#x00633;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00642;&#x00647;&#x00642;&#x00631;&#x0064a;&#x00629; &#x00648;&#x00639;&#x00644;&#x00649; &#x0062a;&#x00641;&#x00627;&#x00642;&#x00645; &#x00645;&#x00631;&#x00636; &#x00641;&#x0064a;&#x00631;&#x00648;&#x00633; &#x00627;&#x00644;&#x00639;&#x00648;&#x00632; &#x00627;&#x00644;&#x00645;&#x00646;&#x00627;&#x00639;&#x0064a; &#x00627;&#x00644;&#x00628;&#x00634;&#x00631;&#x0064a; &#x00648;&#x00639;&#x00644;&#x00649; &#x0062c;&#x00648;&#x0062f;&#x00629; &#x00627;&#x00644;&#x0062d;&#x0064a;&#x00627;&#x00629;. </p></sec></trans-abstract><trans-abstract xml:lang="zh"><title>&#x06458;&#x08981;</title><sec><title>&#x076ee;&#x07684;</title><p>&#x08bc4;&#x04f30;&#x0827e;&#x06ecb;&#x075c5;&#x075c5;&#x06bd2;&#x0ff08;HIV&#x0ff09;&#x0611f;&#x067d3;&#x04e2a;&#x04eba;&#x07684;&#x05c31;&#x04e1a;&#x072b6;&#x051b5;&#x0548c;&#x0575a;&#x06301;&#x06297;&#x09006;&#x08f6c;&#x05f55;&#x075c5;&#x06bd2;&#x07597;&#x06cd5;&#x0ff08;ART&#x0ff09;&#x04e4b;&#x095f4;&#x07684;&#x05173;&#x08054;&#x03002;</p></sec><sec><title>&#x065b9;&#x06cd5;</title><p>&#x06211;&#x04eec;&#x0641c;&#x07d22;&#x04e86;Medline&#x03001;Embase&#x0548c;Cochrane&#x05bf9;&#x07167;&#x08bd5;&#x09a8c;&#x04e2d;&#x05fc3;&#x06ce8;&#x0518c;&#x06570;&#x0636e;&#x05e93;&#x0ff0c;&#x05bfb;&#x0627e;1980&#x05e74;1&#x06708;&#x081f3;2014&#x05e74;9&#x06708;&#x053d1;&#x08868;&#x07684;&#x062a5;&#x0544a;ART&#x0575a;&#x06301;&#x0548c;&#x05c31;&#x04e1a;&#x072b6;&#x051b5;&#x07684;&#x07814;&#x07a76;&#x03002;&#x04e5f;&#x05bf9;&#x06765;&#x081ea;&#x05176;&#x04ed6;&#x06765;&#x06e90;&#x07684;&#x05e7f;&#x06cdb;&#x04fe1;&#x0606f;&#x08fdb;&#x0884c;&#x05206;&#x06790;&#x0ff0c;&#x05176;&#x04e2d;&#x05305;&#x062ec;&#x07070;&#x08272;&#x06587;&#x0732e;&#x03002;&#x07531;&#x04e24;&#x0540d;&#x072ec;&#x07acb;&#x08bc4;&#x05ba1;&#x08005;&#x062bd;&#x053d6;&#x06709;&#x05173;&#x0575a;&#x06301;&#x06cbb;&#x07597;&#x0548c;&#x07814;&#x07a76;&#x07279;&#x070b9;&#x07684;&#x06570;&#x0636e;&#x03002;&#x04f7f;&#x07528;&#x0968f;&#x0673a;&#x06548;&#x05e94;&#x06a21;&#x0578b;&#x06c47;&#x0805a;&#x06709;&#x05173;&#x053d7;&#x096c7;&#x0548c;&#x0575a;&#x06301;ART&#x04e4b;&#x095f4;&#x05173;&#x08054;&#x06027;&#x07684;&#x07814;&#x07a76;&#x06570;&#x0636e;&#x03002;&#x08bc4;&#x04f30;&#x04e86;&#x07814;&#x07a76;&#x095f4;&#x05f02;&#x08d28;&#x06027;&#x0548c;&#x0504f;&#x05dee;&#x06765;&#x06e90;&#x03002;</p></sec><sec><title>&#x07ed3;&#x0679c;</title><p>&#x05143;&#x05206;&#x06790;&#x05305;&#x062ec;&#x04e86;&#x05728;1996&#x05e74;&#x0548c;2014&#x05e74;&#x04e4b;&#x095f4;&#x053d1;&#x05e03;&#x07684;28&#x09879;&#x07814;&#x07a76;&#x0ff0c;&#x05408;&#x08ba1;&#x06d89;&#x053ca;&#x06765;&#x081ea;14&#x04e2a;&#x056fd;&#x05bb6;&#x07684;8743&#x04e2a;HIV&#x0611f;&#x067d3;&#x04e2a;&#x04eba;&#x03002;&#x053d7;&#x096c7;&#x0548c;&#x0575a;&#x06301;ART&#x04e4b;&#x095f4;&#x05173;&#x08054;&#x07684;&#x0603b;&#x04f53;&#x06c47;&#x0603b;&#x04f18;&#x052bf;&#x06bd4;&#x0ff08;OR&#x0ff09;&#x04e3a;1.27&#x0ff08;95%&#x07f6e;&#x04fe1;&#x0533a;&#x095f4;&#x0ff0c;CI&#x0ff1a;1.04&#x02013;1.55&#x0ff09;&#x03002;&#x06765;&#x081ea;&#x04f4e;&#x06536;&#x05165;&#x056fd;&#x05bb6;&#x07684;&#x07814;&#x07a76;&#x07684;&#x05173;&#x08054;&#x06bd4;&#x08f83;&#x0660e;&#x0663e;&#x0ff08;OR&#x0ff1a;&#x02009;1.85&#x0ff0c;95% CI&#x0ff1a;1.58&#x02013;2.18&#x0ff09;&#x0ff0c;&#x09ad8;&#x06536;&#x05165;&#x056fd;&#x05bb6;&#x04e5f;&#x0662f;&#x05982;&#x06b64;&#x0ff08;OR&#x0ff1a;&#x02009;1.33&#x0ff0c;95% CI&#x0ff1a;1.02&#x02013;1.74&#x0ff09;&#x0ff0c;&#x04f46;&#x04e2d;&#x07b49;&#x06536;&#x05165;&#x05219;&#x04e0d;&#x07136;&#x0ff08;OR&#x0ff1a;&#x02009;0.94&#x0ff0c;95% CI&#x0ff1a;0.62&#x02013;1.42&#x0ff09;&#x03002;&#x06b64;&#x05916;&#x0ff0c;&#x05728;2011&#x05e74;&#x04e4b;&#x0540e;&#x053d1;&#x08868;&#x07684;&#x07814;&#x07a76;&#x0548c;&#x066f4;&#x05927;&#x07684;&#x07814;&#x07a76;&#x0663e;&#x0793a;&#x051fa;&#x07684;&#x05c31;&#x04e1a;&#x0548c;&#x0575a;&#x06301;&#x06cbb;&#x07597;&#x04e4b;&#x095f4;&#x07684;&#x05173;&#x08054;&#x05206;&#x0522b;&#x05747;&#x06bd4;&#x08f83;&#x065e9;&#x0548c;&#x08f83;&#x05c0f;&#x07814;&#x07a76;&#x066f4;&#x05c0f;&#x03002;</p></sec><sec><title>&#x07ed3;&#x08bba;</title><p>&#x08f83;&#x04e4b;&#x05931;&#x04e1a;&#x07684;&#x04e2a;&#x04eba;&#x0ff0c;&#x05c31;&#x04e1a;&#x07684;HIV&#x0611f;&#x067d3;&#x04e2a;&#x04eba;&#x0ff08;&#x05c24;&#x05176;&#x05728;&#x04f4e;&#x06536;&#x05165;&#x0548c;&#x09ad8;&#x06536;&#x05165;&#x056fd;&#x05bb6;&#x0ff09;&#x066f4;&#x053ef;&#x080fd;&#x0575a;&#x06301;ART&#x03002;&#x09700;&#x08981;&#x08fdb;&#x04e00;&#x06b65;&#x07814;&#x07a76;&#x06765;&#x04e86;&#x089e3;&#x05c31;&#x04e1a;&#x0548c;&#x0575a;&#x06301;ART&#x076f8;&#x04e92;&#x05f71;&#x054cd;&#x07684;&#x0673a;&#x05236;&#x0ff0c;&#x04ee5;&#x053ca;&#x0521b;&#x09020;&#x05c31;&#x04e1a;&#x05e72;&#x09884;&#x0662f;&#x05426;&#x05bf9;&#x0575a;&#x06301;ART&#x03001;HIV&#x075be;&#x075c5;&#x06076;&#x05316;&#x0548c;&#x0751f;&#x06d3b;&#x08d28;&#x091cf;&#x06709;&#x079ef;&#x06781;&#x07684;&#x05f71;&#x054cd;&#x03002;</p></sec></trans-abstract><trans-abstract xml:lang="ru"><title>&#x00420;&#x00435;&#x00437;&#x0044e;&#x0043c;&#x00435;</title><sec><title>&#x00426;&#x00435;&#x0043b;&#x0044c;</title><p>&#x0041e;&#x00446;&#x00435;&#x0043d;&#x00438;&#x00442;&#x0044c; &#x00441;&#x00432;&#x0044f;&#x00437;&#x0044c; &#x0043c;&#x00435;&#x00436;&#x00434;&#x00443; &#x00441;&#x00442;&#x00430;&#x00442;&#x00443;&#x00441;&#x0043e;&#x0043c; &#x00437;&#x00430;&#x0043d;&#x0044f;&#x00442;&#x0043e;&#x00441;&#x00442;&#x00438; &#x0043b;&#x00438;&#x00446;, &#x00438;&#x0043d;&#x00444;&#x00438;&#x00446;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x00432;&#x00438;&#x00440;&#x00443;&#x00441;&#x0043e;&#x0043c; &#x00438;&#x0043c;&#x0043c;&#x00443;&#x0043d;&#x0043e;&#x00434;&#x00435;&#x00444;&#x00438;&#x00446;&#x00438;&#x00442;&#x00430; &#x00447;&#x00435;&#x0043b;&#x0043e;&#x00432;&#x00435;&#x0043a;&#x00430; (&#x00412;&#x00418;&#x00427;), &#x00438; &#x00441;&#x0043e;&#x00431;&#x0043b;&#x0044e;&#x00434;&#x00435;&#x0043d;&#x00438;&#x00435;&#x0043c; &#x00440;&#x00435;&#x00436;&#x00438;&#x0043c;&#x00430; &#x00430;&#x0043d;&#x00442;&#x00438;&#x00440;&#x00435;&#x00442;&#x00440;&#x0043e;&#x00432;&#x00438;&#x00440;&#x00443;&#x00441;&#x0043d;&#x0043e;&#x00439; &#x00442;&#x00435;&#x00440;&#x00430;&#x0043f;&#x00438;&#x00438; (&#x00410;&#x00420;&#x00422;).</p></sec><sec><title>&#x0041c;&#x00435;&#x00442;&#x0043e;&#x00434;&#x0044b;</title><p>&#x00411;&#x0044b;&#x0043b; &#x0043f;&#x00440;&#x0043e;&#x00438;&#x00437;&#x00432;&#x00435;&#x00434;&#x00435;&#x0043d; &#x0043f;&#x0043e;&#x00438;&#x00441;&#x0043a; &#x00440;&#x00430;&#x00431;&#x0043e;&#x00442; &#x00432; &#x00431;&#x00430;&#x00437;&#x00430;&#x00445; &#x00434;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00445; Medline, Embase &#x00438; &#x00432; &#x0041a;&#x0043e;&#x0043a;&#x00440;&#x00430;&#x0043d;&#x0043e;&#x00432;&#x00441;&#x0043a;&#x0043e;&#x0043c; &#x00446;&#x00435;&#x0043d;&#x00442;&#x00440;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x0043c; &#x00440;&#x00435;&#x00435;&#x00441;&#x00442;&#x00440;&#x00435; &#x0043a;&#x0043e;&#x0043d;&#x00442;&#x00440;&#x0043e;&#x0043b;&#x00438;&#x00440;&#x00443;&#x00435;&#x0043c;&#x0044b;&#x00445; &#x0043a;&#x0043b;&#x00438;&#x0043d;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x00438;&#x00445; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00439;, &#x00441;&#x0043e;&#x00434;&#x00435;&#x00440;&#x00436;&#x00430;&#x00449;&#x00438;&#x00445; &#x00434;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x0043e; &#x00441;&#x0043e;&#x00431;&#x0043b;&#x0044e;&#x00434;&#x00435;&#x0043d;&#x00438;&#x00438; &#x0043f;&#x00430;&#x00446;&#x00438;&#x00435;&#x0043d;&#x00442;&#x00430;&#x0043c;&#x00438; &#x00440;&#x00435;&#x00436;&#x00438;&#x0043c;&#x00430; &#x00410;&#x00420;&#x00422; &#x00438; &#x00438;&#x00445; &#x00441;&#x00442;&#x00430;&#x00442;&#x00443;&#x00441;&#x00435; &#x00437;&#x00430;&#x0043d;&#x0044f;&#x00442;&#x0043e;&#x00441;&#x00442;&#x00438;, &#x0043a;&#x0043e;&#x00442;&#x0043e;&#x00440;&#x0044b;&#x00435; &#x00431;&#x0044b;&#x0043b;&#x00438; &#x0043e;&#x0043f;&#x00443;&#x00431;&#x0043b;&#x00438;&#x0043a;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0044b; &#x00432; &#x0043f;&#x00435;&#x00440;&#x00438;&#x0043e;&#x00434; &#x00441; &#x0044f;&#x0043d;&#x00432;&#x00430;&#x00440;&#x0044f; 1980 &#x0043f;&#x0043e; &#x00441;&#x00435;&#x0043d;&#x00442;&#x0044f;&#x00431;&#x00440;&#x0044c; 2014&#x000a0;&#x00433;&#x0043e;&#x00434;&#x00430;. &#x00422;&#x00430;&#x0043a;&#x00436;&#x00435; &#x00431;&#x0044b;&#x0043b;&#x00430; &#x0043f;&#x00440;&#x0043e;&#x00430;&#x0043d;&#x00430;&#x0043b;&#x00438;&#x00437;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00430; &#x00438;&#x0043d;&#x00444;&#x0043e;&#x00440;&#x0043c;&#x00430;&#x00446;&#x00438;&#x0044f; &#x00438;&#x00437; &#x00448;&#x00438;&#x00440;&#x0043e;&#x0043a;&#x0043e;&#x00433;&#x0043e; &#x0043a;&#x00440;&#x00443;&#x00433;&#x00430; &#x00434;&#x00440;&#x00443;&#x00433;&#x00438;&#x00445; &#x00438;&#x00441;&#x00442;&#x0043e;&#x00447;&#x0043d;&#x00438;&#x0043a;&#x0043e;&#x00432;, &#x00432; &#x00442;&#x0043e;&#x0043c; &#x00447;&#x00438;&#x00441;&#x0043b;&#x00435;, &#x0043b;&#x00438;&#x00442;&#x00435;&#x00440;&#x00430;&#x00442;&#x00443;&#x00440;&#x0044b;, &#x0043d;&#x00435; &#x00438;&#x0043d;&#x00434;&#x00435;&#x0043a;&#x00441;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0043e;&#x00439; &#x00432; &#x0043c;&#x00435;&#x00434;&#x00438;&#x00446;&#x00438;&#x0043d;&#x00441;&#x0043a;&#x00438;&#x00445; &#x00431;&#x00430;&#x00437;&#x00430;&#x00445; &#x00434;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00445;. &#x00414;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x0043e; &#x00441;&#x0043e;&#x00431;&#x0043b;&#x0044e;&#x00434;&#x00435;&#x0043d;&#x00438;&#x00438; &#x00440;&#x00435;&#x00436;&#x00438;&#x0043c;&#x00430; &#x0043b;&#x00435;&#x00447;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00438; &#x00445;&#x00430;&#x00440;&#x00430;&#x0043a;&#x00442;&#x00435;&#x00440;&#x00438;&#x00441;&#x00442;&#x00438;&#x0043a;&#x00430;&#x00445; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00438;&#x00439; &#x0043e;&#x00442;&#x00431;&#x00438;&#x00440;&#x00430;&#x0043b;&#x00438;&#x00441;&#x0044c; &#x00434;&#x00432;&#x00443;&#x0043c;&#x0044f; &#x0043d;&#x00435;&#x00437;&#x00430;&#x00432;&#x00438;&#x00441;&#x00438;&#x0043c;&#x0044b;&#x0043c;&#x00438; &#x0044d;&#x0043a;&#x00441;&#x0043f;&#x00435;&#x00440;&#x00442;&#x00430;&#x0043c;&#x00438;. &#x00414;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00438;&#x00439; &#x0043e; &#x00441;&#x00432;&#x0044f;&#x00437;&#x00438; &#x0043c;&#x00435;&#x00436;&#x00434;&#x00443; &#x00437;&#x00430;&#x0043d;&#x0044f;&#x00442;&#x0043e;&#x00441;&#x00442;&#x0044c;&#x0044e; &#x00438; &#x00441;&#x0043e;&#x00431;&#x0043b;&#x0044e;&#x00434;&#x00435;&#x0043d;&#x00438;&#x00435;&#x0043c; &#x00440;&#x00435;&#x00436;&#x00438;&#x0043c;&#x00430; &#x00410;&#x00420;&#x00422; &#x00431;&#x0044b;&#x0043b;&#x00438; &#x0043e;&#x00431;&#x0044a;&#x00435;&#x00434;&#x00438;&#x0043d;&#x00435;&#x0043d;&#x0044b; &#x00441; &#x00438;&#x00441;&#x0043f;&#x0043e;&#x0043b;&#x0044c;&#x00437;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00435;&#x0043c; &#x0043c;&#x0043e;&#x00434;&#x00435;&#x0043b;&#x00438; &#x00441;&#x0043b;&#x00443;&#x00447;&#x00430;&#x00439;&#x0043d;&#x0044b;&#x00445; &#x0044d;&#x00444;&#x00444;&#x00435;&#x0043a;&#x00442;&#x0043e;&#x00432;. &#x00411;&#x0044b;&#x0043b;&#x00430; &#x0043e;&#x00446;&#x00435;&#x0043d;&#x00435;&#x0043d;&#x00430; &#x00433;&#x00435;&#x00442;&#x00435;&#x00440;&#x0043e;&#x00433;&#x00435;&#x0043d;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x0044c; &#x0043c;&#x00435;&#x00436;&#x00434;&#x00443; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f;&#x0043c;&#x00438; &#x00438; &#x00438;&#x00441;&#x00442;&#x0043e;&#x00447;&#x0043d;&#x00438;&#x0043a;&#x00438; &#x0043e;&#x00448;&#x00438;&#x00431;&#x0043e;&#x0043a;.</p></sec><sec><title>&#x00420;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442;&#x0044b;</title><p>&#x00412; &#x0043c;&#x00435;&#x00442;&#x00430;-&#x00430;&#x0043d;&#x00430;&#x0043b;&#x00438;&#x00437; &#x00431;&#x0044b;&#x0043b;&#x0043e; &#x00432;&#x0043a;&#x0043b;&#x0044e;&#x00447;&#x00435;&#x0043d;&#x0043e; 28&#x000a0;&#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00439;, &#x0043e;&#x0043f;&#x00443;&#x00431;&#x0043b;&#x00438;&#x0043a;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x00432; &#x0043f;&#x00435;&#x00440;&#x00438;&#x0043e;&#x00434; &#x00441; 1996 &#x0043f;&#x0043e; 2014&#x000a0;&#x00433;&#x00433;., &#x0043a;&#x0043e;&#x00442;&#x0043e;&#x00440;&#x0044b;&#x00435; &#x00432; &#x00441;&#x0043e;&#x00432;&#x0043e;&#x0043a;&#x00443;&#x0043f;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438; &#x00441;&#x0043e;&#x00434;&#x00435;&#x00440;&#x00436;&#x00430;&#x0043b;&#x00438; &#x00434;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x0043f;&#x0043e; 8743&#x000a0;&#x00412;&#x00418;&#x00427;-&#x00438;&#x0043d;&#x00444;&#x00438;&#x00446;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x0043c; &#x0043b;&#x00438;&#x00446;&#x00430;&#x0043c; &#x00438;&#x00437; 14&#x000a0;&#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;. &#x00421;&#x00443;&#x0043c;&#x0043c;&#x00430;&#x00440;&#x0043d;&#x0043e;&#x00435; &#x0043e;&#x00431;&#x0043e;&#x00431;&#x00449;&#x00435;&#x0043d;&#x0043d;&#x0043e;&#x00435; &#x0043e;&#x00442;&#x0043d;&#x0043e;&#x00448;&#x00435;&#x0043d;&#x00438;&#x00435; &#x00448;&#x00430;&#x0043d;&#x00441;&#x0043e;&#x00432; (&#x0041e;&#x00428;) &#x00434;&#x0043b;&#x0044f; &#x00441;&#x00432;&#x0044f;&#x00437;&#x00438; &#x0043c;&#x00435;&#x00436;&#x00434;&#x00443; &#x00437;&#x00430;&#x0043d;&#x0044f;&#x00442;&#x0043e;&#x00441;&#x00442;&#x0044c;&#x0044e; &#x00438; &#x00441;&#x0043e;&#x00431;&#x0043b;&#x0044e;&#x00434;&#x00435;&#x0043d;&#x00438;&#x00435;&#x0043c; &#x00440;&#x00435;&#x00436;&#x00438;&#x0043c;&#x00430; &#x00410;&#x00420;&#x00422; &#x00441;&#x0043e;&#x00441;&#x00442;&#x00430;&#x00432;&#x00438;&#x0043b;&#x0043e; 1,27 (95%-&#x0043d;&#x0044b;&#x00439; &#x00434;&#x0043e;&#x00432;&#x00435;&#x00440;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00439; &#x00438;&#x0043d;&#x00442;&#x00435;&#x00440;&#x00432;&#x00430;&#x0043b;, &#x00414;&#x00418;: 1,04&#x02013;1,55). &#x0042d;&#x00442;&#x00430; &#x00441;&#x00432;&#x0044f;&#x00437;&#x0044c; &#x00431;&#x0044b;&#x0043b;&#x00430; &#x00441;&#x00443;&#x00449;&#x00435;&#x00441;&#x00442;&#x00432;&#x00435;&#x0043d;&#x0043d;&#x0043e;&#x00439; &#x00432; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f;&#x00445;, &#x00432;&#x0044b;&#x0043f;&#x0043e;&#x0043b;&#x0043d;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x00432; &#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00430;&#x00445; &#x00441; &#x0043d;&#x00438;&#x00437;&#x0043a;&#x00438;&#x0043c; &#x00443;&#x00440;&#x0043e;&#x00432;&#x0043d;&#x00435;&#x0043c; &#x00434;&#x0043e;&#x00445;&#x0043e;&#x00434;&#x00430; (&#x0041e;&#x00428;:&#x02009;1,85; 95%-&#x0043d;&#x0044b;&#x00439; &#x00414;&#x00418;: 1,58&#x02013;2,18) &#x00438; &#x00432; &#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00430;&#x00445; &#x00441; &#x00432;&#x0044b;&#x00441;&#x0043e;&#x0043a;&#x00438;&#x0043c; &#x00443;&#x00440;&#x0043e;&#x00432;&#x0043d;&#x00435;&#x0043c; &#x00434;&#x0043e;&#x00445;&#x0043e;&#x00434;&#x00430; (&#x0041e;&#x00428;:&#x02009;1,33; 95%-&#x0043d;&#x0044b;&#x00439; &#x00414;&#x00418;: 1,02&#x02013;1,74), &#x0043d;&#x0043e; &#x0043d;&#x00435; &#x00432; &#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00430;&#x00445; &#x00441;&#x0043e; &#x00441;&#x00440;&#x00435;&#x00434;&#x0043d;&#x00438;&#x0043c; &#x00443;&#x00440;&#x0043e;&#x00432;&#x0043d;&#x00435;&#x0043c; &#x00434;&#x0043e;&#x00445;&#x0043e;&#x00434;&#x00430; (&#x0041e;&#x00428;:&#x02009;0,94; 95%-&#x0043d;&#x0044b;&#x00439; &#x00414;&#x00418;: 0,62&#x02013;1,42). &#x0041a;&#x00440;&#x0043e;&#x0043c;&#x00435; &#x00442;&#x0043e;&#x00433;&#x0043e;, &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f;, &#x0043e;&#x0043f;&#x00443;&#x00431;&#x0043b;&#x00438;&#x0043a;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x0043f;&#x0043e;&#x00441;&#x0043b;&#x00435; 2011&#x000a0;&#x00433;&#x0043e;&#x00434;&#x00430;, &#x00438; &#x00431;&#x0043e;&#x0043b;&#x00435;&#x00435; &#x0043a;&#x00440;&#x00443;&#x0043f;&#x0043d;&#x0044b;&#x00435; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f; &#x0043f;&#x0043e;&#x0043a;&#x00430;&#x00437;&#x00430;&#x0043b;&#x00438; &#x0043c;&#x00435;&#x0043d;&#x0044c;&#x00448;&#x00443;&#x0044e; &#x00441;&#x00432;&#x0044f;&#x00437;&#x0044c; &#x0043c;&#x00435;&#x00436;&#x00434;&#x00443; &#x00437;&#x00430;&#x0043d;&#x0044f;&#x00442;&#x0043e;&#x00441;&#x00442;&#x0044c;&#x0044e; &#x00438; &#x00441;&#x0043e;&#x00431;&#x0043b;&#x0044e;&#x00434;&#x00435;&#x0043d;&#x00438;&#x00435;&#x0043c; &#x00440;&#x00435;&#x00436;&#x00438;&#x0043c;&#x00430; &#x00442;&#x00435;&#x00440;&#x00430;&#x0043f;&#x00438;&#x00438; &#x0043f;&#x0043e; &#x00441;&#x00440;&#x00430;&#x00432;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x0044e; &#x00441; &#x00431;&#x0043e;&#x0043b;&#x00435;&#x00435; &#x00440;&#x00430;&#x0043d;&#x0043d;&#x00438;&#x0043c;&#x00438; &#x00438; &#x0043c;&#x00435;&#x0043d;&#x0044c;&#x00448;&#x00438;&#x0043c;&#x00438; &#x0043f;&#x0043e; &#x0043c;&#x00430;&#x00441;&#x00448;&#x00442;&#x00430;&#x00431;&#x00443; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f;&#x0043c;&#x00438; &#x00441;&#x0043e;&#x0043e;&#x00442;&#x00432;&#x00435;&#x00442;&#x00441;&#x00442;&#x00432;&#x00435;&#x0043d;&#x0043d;&#x0043e;.</p></sec><sec><title>&#x00412;&#x0044b;&#x00432;&#x0043e;&#x00434;</title><p>&#x00418;&#x0043c;&#x00435;&#x0044e;&#x00449;&#x00438;&#x00435; &#x00442;&#x00440;&#x00443;&#x00434;&#x0043e;&#x00432;&#x00443;&#x0044e; &#x00437;&#x00430;&#x0043d;&#x0044f;&#x00442;&#x0043e;&#x00441;&#x00442;&#x0044c; &#x00412;&#x00418;&#x00427;-&#x00438;&#x0043d;&#x00444;&#x00438;&#x00446;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x0043b;&#x00438;&#x00446;&#x00430;, &#x0043e;&#x00441;&#x0043e;&#x00431;&#x00435;&#x0043d;&#x0043d;&#x0043e; &#x00432; &#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00430;&#x00445; &#x00441; &#x0043d;&#x00438;&#x00437;&#x0043a;&#x00438;&#x0043c; &#x00438; &#x00432;&#x0044b;&#x00441;&#x0043e;&#x0043a;&#x00438;&#x0043c; &#x00443;&#x00440;&#x0043e;&#x00432;&#x0043d;&#x00435;&#x0043c; &#x00434;&#x0043e;&#x00445;&#x0043e;&#x00434;&#x00430;, &#x00432; &#x00431;&#x0043e;&#x0043b;&#x0044c;&#x00448;&#x00438;&#x0043d;&#x00441;&#x00442;&#x00432;&#x00435; &#x00441;&#x00432;&#x0043e;&#x00435;&#x0043c;, &#x00441;&#x0043e;&#x00431;&#x0043b;&#x0044e;&#x00434;&#x00430;&#x0043b;&#x00438; &#x00440;&#x00435;&#x00436;&#x00438;&#x0043c; &#x00410;&#x00420;&#x00422;, &#x0043f;&#x0043e; &#x00441;&#x00440;&#x00430;&#x00432;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x0044e; &#x00441; &#x00431;&#x00435;&#x00437;&#x00440;&#x00430;&#x00431;&#x0043e;&#x00442;&#x0043d;&#x0044b;&#x0043c;&#x00438; &#x0043b;&#x00438;&#x00446;&#x00430;&#x0043c;&#x00438;. &#x0041d;&#x00435;&#x0043e;&#x00431;&#x00445;&#x0043e;&#x00434;&#x00438;&#x0043c;&#x0044b; &#x00434;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x00435;&#x00439;&#x00448;&#x00438;&#x00435; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f; &#x0043c;&#x00435;&#x00445;&#x00430;&#x0043d;&#x00438;&#x00437;&#x0043c;&#x0043e;&#x00432; &#x00432;&#x00437;&#x00430;&#x00438;&#x0043c;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x00432;&#x0043b;&#x00438;&#x0044f;&#x0043d;&#x00438;&#x0044f; &#x00437;&#x00430;&#x0043d;&#x0044f;&#x00442;&#x0043e;&#x00441;&#x00442;&#x00438; &#x0043d;&#x00430; &#x00441;&#x0043e;&#x00431;&#x0043b;&#x0044e;&#x00434;&#x00435;&#x0043d;&#x00438;&#x00435; &#x00440;&#x00435;&#x00436;&#x00438;&#x0043c;&#x00430; &#x00410;&#x00420;&#x00422;, &#x00430; &#x00442;&#x00430;&#x0043a;&#x00436;&#x00435; &#x00432;&#x0043e;&#x00437;&#x0043c;&#x0043e;&#x00436;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438; &#x0043f;&#x0043e;&#x0043b;&#x0043e;&#x00436;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x00432;&#x0043b;&#x00438;&#x0044f;&#x0043d;&#x00438;&#x0044f; &#x0043c;&#x00435;&#x00440; &#x0043f;&#x0043e; &#x00441;&#x0043e;&#x00437;&#x00434;&#x00430;&#x0043d;&#x00438;&#x0044e; &#x00437;&#x00430;&#x0043d;&#x0044f;&#x00442;&#x0043e;&#x00441;&#x00442;&#x00438; &#x0043d;&#x00430; &#x00441;&#x0043e;&#x00431;&#x0043b;&#x0044e;&#x00434;&#x00435;&#x0043d;&#x00438;&#x00435; &#x00440;&#x00435;&#x00436;&#x00438;&#x0043c;&#x00430; &#x00410;&#x00420;&#x00422;, &#x0043f;&#x00440;&#x0043e;&#x00433;&#x00440;&#x00435;&#x00441;&#x00441;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00435; &#x00412;&#x00418;&#x00427;-&#x00438;&#x0043d;&#x00444;&#x00435;&#x0043a;&#x00446;&#x00438;&#x00438; &#x00438; &#x0043a;&#x00430;&#x00447;&#x00435;&#x00441;&#x00442;&#x00432;&#x0043e; &#x00436;&#x00438;&#x00437;&#x0043d;&#x00438;.</p></sec></trans-abstract></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Recent data from the World Health Organization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS) indicate that access to human immunodeficiency virus (HIV) treatment and care services in low- and middle-income countries has expanded dramatically.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref> In 2012, over 9.7 million people living with HIV in these countries were receiving antiretroviral therapy (ART).<xref rid="R1" ref-type="bibr"><sup>1</sup></xref></p><p>Despite this increase, ensuring adherence to HIV treatment remains challenging in all countries. A meta-analysis of patients in North America (<italic>n</italic>&#x02009;=&#x02009;17&#x02009;573) and Africa (<italic>n</italic>&#x02009;=&#x02009;12&#x02009;116) estimated that only 55% and 77% in these areas, respectively, achieved over &#x02009;80% adherence<xref rid="R2" ref-type="bibr"><sup>2</sup></xref> and a global meta-analysis, which included 33&#x02009;199 patients on ART, reported that only 62% achieved over 90% adherence.<xref rid="R3" ref-type="bibr"><sup>3</sup></xref> Common barriers to adherence include medication side-effects, pill burden, the need to disclose HIV serostatus, a perception of feeling well, treatment fatigue and structural and psychosocial factors.<xref rid="R4" ref-type="bibr"><sup>4</sup></xref><sup>,</sup><xref rid="R5" ref-type="bibr"><sup>5</sup></xref> For individuals, nonadherence can result in virological treatment failure, the development of drug resistance, disease progression and death.<xref rid="R6" ref-type="bibr"><sup>6</sup></xref><sup>&#x02013;</sup><xref rid="R9" ref-type="bibr"><sup>9</sup></xref> At the community level, nonadherence makes HIV transmission more likely,<xref rid="R10" ref-type="bibr"><sup>10</sup></xref><sup>,</sup><xref rid="R11" ref-type="bibr"><sup>11</sup></xref> can substantially increase health-care costs, particularly for hospitalization to treat opportunistic infections,<xref rid="R12" ref-type="bibr"><sup>12</sup></xref> and can decrease productivity.<xref rid="R13" ref-type="bibr"><sup>13</sup></xref> One factor that has not been explored in depth is whether an individual&#x02019;s employment status influences adherence to ART.<xref rid="R14" ref-type="bibr"><sup>14</sup></xref><sup>,</sup><xref rid="R15" ref-type="bibr"><sup>15</sup></xref></p><p>Adherence to ART may be influenced by factors associated with the disease and its treatment, with the relationship between the patient and the health-care provider and with patients themselves, such as socioeconomic status which is often based on employment or occupational status in addition to educational level and income.<xref rid="R14" ref-type="bibr"><sup>14</sup></xref><sup>,</sup><xref rid="R16" ref-type="bibr"><sup>16</sup></xref> Moreover, differences in adherence between people employed in the informal and the formal economy have been linked to gender roles and inequalities in employment status.<xref rid="R17" ref-type="bibr"><sup>17</sup></xref><sup>,</sup><xref rid="R18" ref-type="bibr"><sup>18</sup></xref> A previous meta-analysis by our collaborative research group found that employed HIV-infected patients from low-, middle- and high-income countries were 39% more likely to adhere to ART than unemployed patients. However, the study included very few participants from middle- and low-income countries and therefore did not have sufficient statistical power to determine whether a country&#x02019;s income level had a significant effect on the association between employment status and ART adherence.<xref rid="R19" ref-type="bibr"><sup>19</sup></xref></p><p>The aim of this systematic review and meta-analysis was to investigate the relationship between the employment status of HIV-infected individuals and ART adherence using updated data and a larger patient sample, which included more information from middle- and low-income countries.</p></sec><sec sec-type="methods"><title>Methods</title><p>This meta-analysis was reported in accordance with the <italic>Preferred reporting items for systematic reviews and meta-Analyses: the PRISMA statement</italic>.<xref rid="R20" ref-type="bibr"><sup>20</sup></xref> Studies of any design were included if they satisfied the following criteria: (i)&#x000a0;the study involved people living with HIV; (ii)&#x000a0;participants were receiving highly active antiretroviral therapy; (iii)&#x000a0;treatment adherence was assessed using objective or self-reported measures; and (iv)&#x000a0;employment was considered a possible factor influencing adherence.</p><p>We searched the Medline, Embase and Cochrane Central Register of Controlled Trials databases for the period January 1980 to September 2014 (<xref ref-type="boxed-text" rid="B1">Box&#x000a0;1</xref>). In addition, we used a narrative literature review approach to analyse and summarize information on HIV treatment, particularly on adherence, from a range of sources including UNAIDS secretariat reports, scientific conference abstracts and other grey literature. We contacted individual researchers for details of unpublished studies.</p><boxed-text id="B1" position="float" orientation="portrait"><label>Box&#x000a0;1</label><caption><title>Search terms used for studies on the association between employment status and adherence to antiretroviral therapy</title></caption><p>1. hiv infections/</p><p>2. HIV.ti.</p><p>3. human immunodeficiency virus.ti,ab.</p><p>4. HIV Infections/pc</p><p>5. HIV/ or HIV-1/</p><p>6. Acquired Immunodeficiency Syndrome/pc [Prevention &#x00026; Control]</p><p>7. exp hiv/</p><p>8. exp hiv-1/</p><p>9. exp hiv-2/</p><p>10. Human immunodeficiency virus.mp.</p><p>11. hiv.mp.</p><p>12. or/ No. 1&#x02013;11</p><p>13. blue collar.mp.</p><p>14. blue collar.ti,ab.</p><p>15. white collar.mp.</p><p>16. exp Social Class/</p><p>17. exp Adult/ or Occupations/</p><p>18. Agriculture/ec, ed, ma [Economics, Education, Manpower]</p><p>19. exp Employment/</p><p>20. job.mp.</p><p>21. exp work/</p><p>22. exp income/</p><p>23. manpower.mp.</p><p>24. socioeconomic.mp.</p><p>25. socio-economic.mp.</p><p>26. office.mp.</p><p>27. or/No. 13&#x02013;26</p><p>28. exp Medication Adherence/</p><p>29. Adherence.mp.</p><p>30. Nonadherence.mp.</p><p>31. Compliance.mp.</p><p>32. or/ No. 28&#x02013;31</p><p>33. No. 12 and 27 and 32</p></boxed-text><p>Two reviewers evaluated the eligibility of the studies identified and a third reviewer provided arbitration if there was a discrepancy. One reviewer extracted data, which were checked by others. The quality of the studies included was assessed using the Risk of Bias Assessment tool for Non-randomized Studies (RoBANS; details available from the corresponding author on request).<xref rid="R21" ref-type="bibr"><sup>21</sup></xref> The risk of bias in a study was graded as low, high or unclear on the basis of study features including the selection of participants (selection bias), consideration of confounding variables (selection bias), outcome measurement (detection bias), incomplete outcome data (attrition bias) and selective outcome reporting (reporting bias).</p><sec><title>Data extraction</title><p>For each study included, we recorded: the first author&#x02019;s last name; the year of publication; the country where the study was performed; details of the study design; the years when data were collected; the type of controls in case&#x02013;control studies; the duration of follow-up in cohort studies; sample size; details of exposure measures, such as indicators of occupation or employment; age; sex; the odds that an employed patient versus an unemployed patient would adhere to ART; and the variables controlled for. Study countries were classified by geographical area and categorized as low-, middle- or high-income, as defined by the World Bank for 2014.<xref rid="R22" ref-type="bibr"><sup>22</sup></xref> Study participants were defined as being of working age either by the study investigators or using the International Labour Organization&#x02019;s standard definition.<xref rid="R23" ref-type="bibr"><sup>23</sup></xref> In addition, the International Labour Organization&#x02019;s definition of employment was applied: Persons in employment comprise all persons above a specified age who during a specified brief period, either one week or one day, were in the following categories: paid employment and self-employment.<xref rid="R24" ref-type="bibr"><sup>24</sup></xref></p><p>Consequently, studies were considered eligible if their authors defined employed people as those who, during a specified brief period such as one week or one day: (i)&#x000a0;performed some work for wage or salary in cash or in kind; (ii)&#x000a0;had a formal attachment to a job but were temporarily not at work during the reference period; (iii)&#x000a0;performed some work for profit or family gain in cash or in kind; or (iv)&#x000a0;were with an enterprise such as a business, farm or service but who were temporarily not at work during the reference period for any specific reason.<xref rid="R24" ref-type="bibr"><sup>24</sup></xref></p></sec><sec><title>Data synthesis</title><p>The meta-analysis was performed using the DerSimonian and Laird random-effects model to obtain a pooled estimate for the odds ratio (OR) and the associated 95% confidence interval (CI).<xref rid="R25" ref-type="bibr"><sup>25</sup></xref> The model was chosen since it takes into account both within- and between-study variability, as between-study heterogeneity was anticipated. Heterogeneity among studies was assessed by inspecting forest plots of the odds ratios from each study and by using the <italic>&#x003c7;</italic><sup>2</sup> test for heterogeneity, with a 10% level of statistical significance, and the <italic>I<sup>2</sup></italic> statistic, with which a value of 50% represented moderate heterogeneity. We used leave-one-study-out sensitivity analysis to evaluate the stability of the results and to test whether any one study had an excessive influence on the meta-analysis.<xref rid="R26" ref-type="bibr"><sup>26</sup></xref> In addition, we performed subgroup analyses to assess the influence of study design (i.e. cross-sectional versus prospective cohort), the country&#x02019;s income group (i.e. low, middle or high), the adherence threshold and adherence measures. We used the <italic>&#x003c7;</italic><sup>2</sup> test to subgroup differences and reported the <italic>P</italic>-value for interaction between pooled OR and study-level characteristics. We used a variance-weighted, least-squares regression approach to estimate the effect of the year of publication (i.e. trend analysis) and the study sample size on the association between employment status and ART adherence. For all tests, a probability less than 0.05 was considered significant. All statistical tests were two-sided. Analyses were performed using Stata version 12 (StataCorp. LP, College Station, United States of America).</p></sec></sec><sec sec-type="results"><title>Results</title><p>A flow diagram of study selection is shown in <xref ref-type="fig" rid="F1">Fig.&#x000a0;1</xref>. Twenty-eight studies, involving a total of 8743 patients from 14 countries, met criteria for inclusion in the systematic review (<xref ref-type="table" rid="T1">Table&#x000a0;1</xref>).<xref rid="R4" ref-type="bibr"><sup>4</sup></xref><sup>,</sup><xref rid="R27" ref-type="bibr"><sup>27</sup></xref><sup>&#x02013;</sup><xref rid="R53" ref-type="bibr"><sup>53</sup></xref> The studies were carried out between 1996 and 2012 and publication took place between 1996 and 2014. Overall, 24 studies, involving 7484 of 8743 patients (86%), were cross-sectional, whereas the other four were prospective cohort studies. Eight studies, involving 1775 patients (20%), were carried out in the United States, three each were carried out in Ethiopia, India and South Africa and two were carried out in Uganda.</p><fig id="F1" fig-type="figure" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Flowchart showing the selection of studies for the meta-analysis of the association between employment status and adherence to antiretroviral therapy</p></caption><graphic xlink:href="BLT.14.138149-F1"/></fig><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Studies in the meta-analysis of the association between employment status and adherence to antiretroviral therapy, 14 countries, 1996&#x02013;2014</title></caption><table frame="hsides" rules="groups"><col width="82" span="1"/><col width="56" span="1"/><col width="104" span="1"/><col width="96" span="1"/><col width="70" span="1"/><col width="68" span="1"/><col width="93" span="1"/><col width="104" span="1"/><col width="87" span="1"/><col width="53" span="1"/><col width="82" span="1"/><col width="87" span="1"/><col width="79" span="1"/><col width="73" span="1"/><col width="82" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1">First author of study</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Year of publication</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Study period</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Study design</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Study country</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Country's income group<sup>a</sup></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Participants receiving ART at enrolment</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Lower threshold for adherence to ART, %</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Adherence measure</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Sample size, <italic>n</italic></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Male participants, %</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Age of participants,<sup>b</sup> years</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Unemployment, %</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">% ART adherence</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Measure of association<sup>c</sup></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Singh<xref rid="R27" ref-type="bibr"><sup>27</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">1996</td><td valign="top" align="center" rowspan="1" colspan="1">Not reported</td><td valign="top" align="center" rowspan="1" colspan="1">Prospective cohort</td><td valign="top" align="center" rowspan="1" colspan="1">United States</td><td valign="top" align="center" rowspan="1" colspan="1">High</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">80</td><td valign="top" align="center" rowspan="1" colspan="1">Pharmacy refill data</td><td valign="top" align="center" rowspan="1" colspan="1">46</td><td valign="top" align="center" rowspan="1" colspan="1">ND</td><td valign="top" align="center" rowspan="1" colspan="1">23&#x02013;68</td><td valign="top" align="center" rowspan="1" colspan="1">41.0</td><td valign="top" align="center" rowspan="1" colspan="1">63.0</td><td valign="top" align="center" rowspan="1" colspan="1">Unadjusted</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Singh<xref rid="R28" ref-type="bibr"><sup>28</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">1999</td><td valign="top" align="center" rowspan="1" colspan="1">March 1996 to December 1997</td><td valign="top" align="center" rowspan="1" colspan="1">Cross-sectional</td><td valign="top" align="center" rowspan="1" colspan="1">United States</td><td valign="top" align="center" rowspan="1" colspan="1">High</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">Not reported</td><td valign="top" align="center" rowspan="1" colspan="1">Pharmacy refill data</td><td valign="top" align="center" rowspan="1" colspan="1">123</td><td valign="top" align="center" rowspan="1" colspan="1">ND</td><td valign="top" align="center" rowspan="1" colspan="1">24&#x02013;71</td><td valign="top" align="center" rowspan="1" colspan="1">52.8</td><td valign="top" align="center" rowspan="1" colspan="1">82.1</td><td valign="top" align="center" rowspan="1" colspan="1">Unadjusted</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Duong<xref rid="R29" ref-type="bibr"><sup>29</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2001</td><td valign="top" align="center" rowspan="1" colspan="1">Not reported</td><td valign="top" align="center" rowspan="1" colspan="1">Cross-sectional</td><td valign="top" align="center" rowspan="1" colspan="1">France</td><td valign="top" align="center" rowspan="1" colspan="1">High</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">Not reported</td><td valign="top" align="center" rowspan="1" colspan="1">Blood drug concentration</td><td valign="top" align="center" rowspan="1" colspan="1">149</td><td valign="top" align="center" rowspan="1" colspan="1">71.8</td><td valign="top" align="center" rowspan="1" colspan="1">21&#x02013;79</td><td valign="top" align="center" rowspan="1" colspan="1">45.6</td><td valign="top" align="center" rowspan="1" colspan="1">89.0</td><td valign="top" align="center" rowspan="1" colspan="1">Unadjusted</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ickovics<xref rid="R30" ref-type="bibr"><sup>30</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2002</td><td valign="top" align="center" rowspan="1" colspan="1">Not reported</td><td valign="top" align="center" rowspan="1" colspan="1">Cross-sectional from RCT</td><td valign="top" align="center" rowspan="1" colspan="1">United States</td><td valign="top" align="center" rowspan="1" colspan="1">High</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">95</td><td valign="top" align="center" rowspan="1" colspan="1">Self-report questionnaire</td><td valign="top" align="center" rowspan="1" colspan="1">93</td><td valign="top" align="center" rowspan="1" colspan="1">88.0</td><td valign="top" align="center" rowspan="1" colspan="1">19&#x02013;61</td><td valign="top" align="center" rowspan="1" colspan="1">23.9</td><td valign="top" align="center" rowspan="1" colspan="1">63.0</td><td valign="top" align="center" rowspan="1" colspan="1">Adjusted</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Nachega<xref rid="R31" ref-type="bibr"><sup>31</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2004</td><td valign="top" align="center" rowspan="1" colspan="1">Not reported</td><td valign="top" align="center" rowspan="1" colspan="1">Cross-sectional</td><td valign="top" align="center" rowspan="1" colspan="1">South Africa</td><td valign="top" align="center" rowspan="1" colspan="1">Middle</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">95</td><td valign="top" align="center" rowspan="1" colspan="1">Self-report questionnaire</td><td valign="top" align="center" rowspan="1" colspan="1">66</td><td valign="top" align="center" rowspan="1" colspan="1">28.8</td><td valign="top" align="center" rowspan="1" colspan="1">36.1 (10.1)</td><td valign="top" align="center" rowspan="1" colspan="1">40.9</td><td valign="top" align="center" rowspan="1" colspan="1">88.0</td><td valign="top" align="center" rowspan="1" colspan="1">Unadjusted</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Beyene<xref rid="R32" ref-type="bibr"><sup>32</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2009</td><td valign="top" align="center" rowspan="1" colspan="1">August to October 2009</td><td valign="top" align="center" rowspan="1" colspan="1">Cross-sectional</td><td valign="top" align="center" rowspan="1" colspan="1">Ethiopia</td><td valign="top" align="center" rowspan="1" colspan="1">Low</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">95</td><td valign="top" align="center" rowspan="1" colspan="1">Self-report questionnaire</td><td valign="top" align="center" rowspan="1" colspan="1">422</td><td valign="top" align="center" rowspan="1" colspan="1">43.6</td><td valign="top" align="center" rowspan="1" colspan="1">32.2 (7.2)</td><td valign="top" align="center" rowspan="1" colspan="1">59.0</td><td valign="top" align="center" rowspan="1" colspan="1">93.1</td><td valign="top" align="center" rowspan="1" colspan="1">Adjusted</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Duggan<xref rid="R33" ref-type="bibr"><sup>33</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2009</td><td valign="top" align="center" rowspan="1" colspan="1">August to November 2006</td><td valign="top" align="center" rowspan="1" colspan="1">Cross-sectional</td><td valign="top" align="center" rowspan="1" colspan="1">United States</td><td valign="top" align="center" rowspan="1" colspan="1">High</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">Not reported</td><td valign="top" align="center" rowspan="1" colspan="1">Combination of methods</td><td valign="top" align="center" rowspan="1" colspan="1">132</td><td valign="top" align="center" rowspan="1" colspan="1">66.7</td><td valign="top" align="center" rowspan="1" colspan="1">18&#x02013;51</td><td valign="top" align="center" rowspan="1" colspan="1">55.3</td><td valign="top" align="center" rowspan="1" colspan="1">74.2</td><td valign="top" align="center" rowspan="1" colspan="1">Unadjusted</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Nakimuli-Mpungu<xref rid="R34" ref-type="bibr"><sup>34</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2009</td><td valign="top" align="center" rowspan="1" colspan="1">Not reported</td><td valign="top" align="center" rowspan="1" colspan="1">Cross-sectional</td><td valign="top" align="center" rowspan="1" colspan="1">Uganda</td><td valign="top" align="center" rowspan="1" colspan="1">Low</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">90</td><td valign="top" align="center" rowspan="1" colspan="1">Self-report questionnaire</td><td valign="top" align="center" rowspan="1" colspan="1">122</td><td valign="top" align="center" rowspan="1" colspan="1">21.3</td><td valign="top" align="center" rowspan="1" colspan="1">36.0 (8.2)</td><td valign="top" align="center" rowspan="1" colspan="1">34.4</td><td valign="top" align="center" rowspan="1" colspan="1">82.8</td><td valign="top" align="center" rowspan="1" colspan="1">Adjusted</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Campos<xref rid="R35" ref-type="bibr"><sup>35</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2010</td><td valign="top" align="center" rowspan="1" colspan="1">May 2001 to May 2002</td><td valign="top" align="center" rowspan="1" colspan="1">Prospective cohort</td><td valign="top" align="center" rowspan="1" colspan="1">Brazil</td><td valign="top" align="center" rowspan="1" colspan="1">Middle</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">95</td><td valign="top" align="center" rowspan="1" colspan="1">Self-report questionnaire</td><td valign="top" align="center" rowspan="1" colspan="1">293</td><td valign="top" align="center" rowspan="1" colspan="1">65.9</td><td valign="top" align="center" rowspan="1" colspan="1">ND</td><td valign="top" align="center" rowspan="1" colspan="1">35.1</td><td valign="top" align="center" rowspan="1" colspan="1">62.8</td><td valign="top" align="center" rowspan="1" colspan="1">Adjusted</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Giday<xref rid="R36" ref-type="bibr"><sup>36</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2010</td><td valign="top" align="center" rowspan="1" colspan="1">August to September 2008</td><td valign="top" align="center" rowspan="1" colspan="1">Cross-sectional</td><td valign="top" align="center" rowspan="1" colspan="1">Ethiopia</td><td valign="top" align="center" rowspan="1" colspan="1">Low</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">95</td><td valign="top" align="center" rowspan="1" colspan="1">Self-report questionnaire</td><td valign="top" align="center" rowspan="1" colspan="1">510</td><td valign="top" align="center" rowspan="1" colspan="1">38.6</td><td valign="top" align="center" rowspan="1" colspan="1">15&#x02013;63</td><td valign="top" align="center" rowspan="1" colspan="1">39.6</td><td valign="top" align="center" rowspan="1" colspan="1">88.2</td><td valign="top" align="center" rowspan="1" colspan="1">Adjusted</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Kunutsor<xref rid="R37" ref-type="bibr"><sup>37</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2010</td><td valign="top" align="center" rowspan="1" colspan="1">Not reported</td><td valign="top" align="center" rowspan="1" colspan="1">Prospective cohort</td><td valign="top" align="center" rowspan="1" colspan="1">Uganda</td><td valign="top" align="center" rowspan="1" colspan="1">Low</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">95</td><td valign="top" align="center" rowspan="1" colspan="1">Pharmacy refill data</td><td valign="top" align="center" rowspan="1" colspan="1">392</td><td valign="top" align="center" rowspan="1" colspan="1">35.2</td><td valign="top" align="center" rowspan="1" colspan="1">32&#x02013;45</td><td valign="top" align="center" rowspan="1" colspan="1">55.4</td><td valign="top" align="center" rowspan="1" colspan="1">93.1</td><td valign="top" align="center" rowspan="1" colspan="1">Adjusted</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Lal<xref rid="R38" ref-type="bibr"><sup>38</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2010</td><td valign="top" align="center" rowspan="1" colspan="1">2005</td><td valign="top" align="center" rowspan="1" colspan="1">Cross-sectional</td><td valign="top" align="center" rowspan="1" colspan="1">India</td><td valign="top" align="center" rowspan="1" colspan="1">Middle</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">95</td><td valign="top" align="center" rowspan="1" colspan="1">Self-report questionnaire</td><td valign="top" align="center" rowspan="1" colspan="1">300</td><td valign="top" align="center" rowspan="1" colspan="1">72.0</td><td valign="top" align="center" rowspan="1" colspan="1">30&#x02013;45</td><td valign="top" align="center" rowspan="1" colspan="1">31.8</td><td valign="top" align="center" rowspan="1" colspan="1">75.7</td><td valign="top" align="center" rowspan="1" colspan="1">Unadjusted</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Li<xref rid="R39" ref-type="bibr"><sup>39</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2010</td><td valign="top" align="center" rowspan="1" colspan="1">Not reported</td><td valign="top" align="center" rowspan="1" colspan="1">Cross-sectional from RCT</td><td valign="top" align="center" rowspan="1" colspan="1">Thailand</td><td valign="top" align="center" rowspan="1" colspan="1">Middle</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">Self-report questionnaire</td><td valign="top" align="center" rowspan="1" colspan="1">386</td><td valign="top" align="center" rowspan="1" colspan="1">32.7</td><td valign="top" align="center" rowspan="1" colspan="1">38.0 (6.4)</td><td valign="top" align="center" rowspan="1" colspan="1">15.5</td><td valign="top" align="center" rowspan="1" colspan="1">68.6</td><td valign="top" align="center" rowspan="1" colspan="1">Adjusted</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Peltzer<xref rid="R40" ref-type="bibr"><sup>40</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2010</td><td valign="top" align="center" rowspan="1" colspan="1">October 2007 to February 2008</td><td valign="top" align="center" rowspan="1" colspan="1">Cross-sectional</td><td valign="top" align="center" rowspan="1" colspan="1">South Africa</td><td valign="top" align="center" rowspan="1" colspan="1">Middle</td><td valign="top" align="center" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">95</td><td valign="top" align="center" rowspan="1" colspan="1">Self-report questionnaire</td><td valign="top" align="center" rowspan="1" colspan="1">735</td><td valign="top" align="center" rowspan="1" colspan="1">29.8</td><td valign="top" align="center" rowspan="1" colspan="1">ND</td><td valign="top" align="center" rowspan="1" colspan="1">59.6</td><td valign="top" align="center" rowspan="1" colspan="1">82.9</td><td valign="top" align="center" rowspan="1" colspan="1">Unadjusted</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sherr<xref rid="R41" ref-type="bibr"><sup>41</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2010</td><td valign="top" align="center" rowspan="1" colspan="1">2005 to 2006</td><td valign="top" align="center" rowspan="1" colspan="1">Cross-sectional</td><td valign="top" align="center" rowspan="1" colspan="1">United Kingdom</td><td valign="top" align="center" rowspan="1" colspan="1">High</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">Self-report questionnaire</td><td valign="top" align="center" rowspan="1" colspan="1">449</td><td valign="top" align="center" rowspan="1" colspan="1">78.9</td><td valign="top" align="center" rowspan="1" colspan="1">ND</td><td valign="top" align="center" rowspan="1" colspan="1">42.8</td><td valign="top" align="center" rowspan="1" colspan="1">42.8</td><td valign="top" align="center" rowspan="1" colspan="1">Unadjusted</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Venkatesh<xref rid="R42" ref-type="bibr"><sup>42</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2010</td><td valign="top" align="center" rowspan="1" colspan="1">January to April 2008</td><td valign="top" align="center" rowspan="1" colspan="1">Cross-sectional</td><td valign="top" align="center" rowspan="1" colspan="1">India</td><td valign="top" align="center" rowspan="1" colspan="1">Middle</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">95</td><td valign="top" align="center" rowspan="1" colspan="1">Self-report questionnaire</td><td valign="top" align="center" rowspan="1" colspan="1">198</td><td valign="top" align="center" rowspan="1" colspan="1">68.5</td><td valign="top" align="center" rowspan="1" colspan="1">ND</td><td valign="top" align="center" rowspan="1" colspan="1">21.9</td><td valign="top" align="center" rowspan="1" colspan="1">49.0</td><td valign="top" align="center" rowspan="1" colspan="1">Adjusted</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Harris<xref rid="R43" ref-type="bibr"><sup>43</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2011</td><td valign="top" align="center" rowspan="1" colspan="1">June 2004 to December 2005</td><td valign="top" align="center" rowspan="1" colspan="1">Cross-sectional</td><td valign="top" align="center" rowspan="1" colspan="1">Dominican Republic</td><td valign="top" align="center" rowspan="1" colspan="1">Middle</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">95</td><td valign="top" align="center" rowspan="1" colspan="1">Self-report questionnaire</td><td valign="top" align="center" rowspan="1" colspan="1">300</td><td valign="top" align="center" rowspan="1" colspan="1">45.0</td><td valign="top" align="center" rowspan="1" colspan="1">ND</td><td valign="top" align="center" rowspan="1" colspan="1">53.0</td><td valign="top" align="center" rowspan="1" colspan="1">76.0</td><td valign="top" align="center" rowspan="1" colspan="1">Unadjusted</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Juday<xref rid="R4" ref-type="bibr"><sup>4</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2011</td><td valign="top" align="center" rowspan="1" colspan="1">April to May 2007</td><td valign="top" align="center" rowspan="1" colspan="1">Cross-sectional</td><td valign="top" align="center" rowspan="1" colspan="1">United States</td><td valign="top" align="center" rowspan="1" colspan="1">High</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">Self-report questionnaire</td><td valign="top" align="center" rowspan="1" colspan="1">461</td><td valign="top" align="center" rowspan="1" colspan="1">76.1</td><td valign="top" align="center" rowspan="1" colspan="1">44.4 (9.3)</td><td valign="top" align="center" rowspan="1" colspan="1">56.2</td><td valign="top" align="center" rowspan="1" colspan="1">54.0</td><td valign="top" align="center" rowspan="1" colspan="1">Adjusted</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Kyser<xref rid="R44" ref-type="bibr"><sup>44</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2011</td><td valign="top" align="center" rowspan="1" colspan="1">March 2004 to June 2006</td><td valign="top" align="center" rowspan="1" colspan="1">Prospective cohort</td><td valign="top" align="center" rowspan="1" colspan="1">United States</td><td valign="top" align="center" rowspan="1" colspan="1">High</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">Self-report questionnaire</td><td valign="top" align="center" rowspan="1" colspan="1">528</td><td valign="top" align="center" rowspan="1" colspan="1">78.0</td><td valign="top" align="center" rowspan="1" colspan="1">20&#x02013;66</td><td valign="top" align="center" rowspan="1" colspan="1">41.0</td><td valign="top" align="center" rowspan="1" colspan="1">84.0</td><td valign="top" align="center" rowspan="1" colspan="1">Adjusted</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Wakibi<xref rid="R45" ref-type="bibr"><sup>45</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2011</td><td valign="top" align="center" rowspan="1" colspan="1">November 2008 to April 2009</td><td valign="top" align="center" rowspan="1" colspan="1">Cross-sectional</td><td valign="top" align="center" rowspan="1" colspan="1">Kenya</td><td valign="top" align="center" rowspan="1" colspan="1">Low</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">95</td><td valign="top" align="center" rowspan="1" colspan="1">Self-report questionnaire</td><td valign="top" align="center" rowspan="1" colspan="1">403</td><td valign="top" align="center" rowspan="1" colspan="1">35.0</td><td valign="top" align="center" rowspan="1" colspan="1">18&#x02013;64</td><td valign="top" align="center" rowspan="1" colspan="1">34.0</td><td valign="top" align="center" rowspan="1" colspan="1">82.0</td><td valign="top" align="center" rowspan="1" colspan="1">Unadjusted</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">King<xref rid="R46" ref-type="bibr"><sup>46</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2012</td><td valign="top" align="center" rowspan="1" colspan="1">February 2007 to December 2009</td><td valign="top" align="center" rowspan="1" colspan="1">Cross-sectional from RCT</td><td valign="top" align="center" rowspan="1" colspan="1">United States</td><td valign="top" align="center" rowspan="1" colspan="1">High</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">Self-report questionnaire</td><td valign="top" align="center" rowspan="1" colspan="1">326</td><td valign="top" align="center" rowspan="1" colspan="1">72.1</td><td valign="top" align="center" rowspan="1" colspan="1">45.9 (7.6)</td><td valign="top" align="center" rowspan="1" colspan="1">79.0</td><td valign="top" align="center" rowspan="1" colspan="1">60.4</td><td valign="top" align="center" rowspan="1" colspan="1">Adjusted</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Kitshoff<xref rid="R47" ref-type="bibr"><sup>47</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2012</td><td valign="top" align="center" rowspan="1" colspan="1">Not reported</td><td valign="top" align="center" rowspan="1" colspan="1">Cross-sectional</td><td valign="top" align="center" rowspan="1" colspan="1">South Africa</td><td valign="top" align="center" rowspan="1" colspan="1">Middle</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">95</td><td valign="top" align="center" rowspan="1" colspan="1">Pill count</td><td valign="top" align="center" rowspan="1" colspan="1">146</td><td valign="top" align="center" rowspan="1" colspan="1">27.4</td><td valign="top" align="center" rowspan="1" colspan="1">31&#x02013;42</td><td valign="top" align="center" rowspan="1" colspan="1">65.0</td><td valign="top" align="center" rowspan="1" colspan="1">68.0</td><td valign="top" align="center" rowspan="1" colspan="1">Adjusted</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Berhe<xref rid="R48" ref-type="bibr"><sup>48</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2013</td><td valign="top" align="center" rowspan="1" colspan="1">August 2012 to October 2012</td><td valign="top" align="center" rowspan="1" colspan="1">Cross-sectional</td><td valign="top" align="center" rowspan="1" colspan="1">Ethiopia</td><td valign="top" align="center" rowspan="1" colspan="1">Low</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">95</td><td valign="top" align="center" rowspan="1" colspan="1">Self-report questionnaire</td><td valign="top" align="center" rowspan="1" colspan="1">174</td><td valign="top" align="center" rowspan="1" colspan="1">46.0</td><td valign="top" align="center" rowspan="1" colspan="1">38.5 (8.4)</td><td valign="top" align="center" rowspan="1" colspan="1">20.1</td><td valign="top" align="center" rowspan="1" colspan="1">40.8</td><td valign="top" align="center" rowspan="1" colspan="1">Adjusted</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Okoronkwo<xref rid="R49" ref-type="bibr"><sup>49</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2013</td><td valign="top" align="center" rowspan="1" colspan="1">Not reported</td><td valign="top" align="center" rowspan="1" colspan="1">Cross-sectional</td><td valign="top" align="center" rowspan="1" colspan="1">Nigeria</td><td valign="top" align="center" rowspan="1" colspan="1">Middle</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">Self-report questionnaire</td><td valign="top" align="center" rowspan="1" colspan="1">221</td><td valign="top" align="center" rowspan="1" colspan="1">ND</td><td valign="top" align="center" rowspan="1" colspan="1">ND</td><td valign="top" align="center" rowspan="1" colspan="1">21.8</td><td valign="top" align="center" rowspan="1" colspan="1">14.9</td><td valign="top" align="center" rowspan="1" colspan="1">Unadjusted</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Vissman<xref rid="R50" ref-type="bibr"><sup>50</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2013</td><td valign="top" align="center" rowspan="1" colspan="1">November 2008 to April 2009</td><td valign="top" align="center" rowspan="1" colspan="1">Cross-sectional</td><td valign="top" align="center" rowspan="1" colspan="1">United States</td><td valign="top" align="center" rowspan="1" colspan="1">High</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">Self-report questionnaire</td><td valign="top" align="center" rowspan="1" colspan="1">66</td><td valign="top" align="center" rowspan="1" colspan="1">74.0</td><td valign="top" align="center" rowspan="1" colspan="1">38.0 (10.3)</td><td valign="top" align="center" rowspan="1" colspan="1">52.0</td><td valign="top" align="center" rowspan="1" colspan="1">71.0</td><td valign="top" align="center" rowspan="1" colspan="1">Unadjusted</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Tran<xref rid="R51" ref-type="bibr"><sup>51</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2013</td><td valign="top" align="center" rowspan="1" colspan="1">2012</td><td valign="top" align="center" rowspan="1" colspan="1">Cross-sectional</td><td valign="top" align="center" rowspan="1" colspan="1">Viet Nam</td><td valign="top" align="center" rowspan="1" colspan="1">Middle</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">95</td><td valign="top" align="center" rowspan="1" colspan="1">Self-report questionnaire</td><td valign="top" align="center" rowspan="1" colspan="1">1016</td><td valign="top" align="center" rowspan="1" colspan="1">63.8</td><td valign="top" align="center" rowspan="1" colspan="1">35.4 (7.0)</td><td valign="top" align="center" rowspan="1" colspan="1">17.8</td><td valign="top" align="center" rowspan="1" colspan="1">74.1</td><td valign="top" align="center" rowspan="1" colspan="1">Adjusted</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Saha<xref rid="R52" ref-type="bibr"><sup>52</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2014</td><td valign="top" align="center" rowspan="1" colspan="1">2011</td><td valign="top" align="center" rowspan="1" colspan="1">Cross-sectional</td><td valign="top" align="center" rowspan="1" colspan="1">India</td><td valign="top" align="center" rowspan="1" colspan="1">Middle</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">Self-report questionnaire</td><td valign="top" align="center" rowspan="1" colspan="1">370</td><td valign="top" align="center" rowspan="1" colspan="1">58.4</td><td valign="top" align="center" rowspan="1" colspan="1">33.5 (8.5)</td><td valign="top" align="center" rowspan="1" colspan="1">33.0</td><td valign="top" align="center" rowspan="1" colspan="1">87.6</td><td valign="top" align="center" rowspan="1" colspan="1">Adjusted</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Shigdel<xref rid="R53" ref-type="bibr"><sup>53</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">2014</td><td valign="top" align="center" rowspan="1" colspan="1">2012</td><td valign="top" align="center" rowspan="1" colspan="1">Cross-sectional</td><td valign="top" align="center" rowspan="1" colspan="1">Nepal</td><td valign="top" align="center" rowspan="1" colspan="1">Low</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">95</td><td valign="top" align="center" rowspan="1" colspan="1">Self-report questionnaire</td><td valign="top" align="center" rowspan="1" colspan="1">316</td><td valign="top" align="center" rowspan="1" colspan="1">64.6</td><td valign="top" align="center" rowspan="1" colspan="1">ND</td><td valign="top" align="center" rowspan="1" colspan="1">22.5</td><td valign="top" align="center" rowspan="1" colspan="1">86.7</td><td valign="top" align="center" rowspan="1" colspan="1">Adjusted</td></tr></tbody></table><table-wrap-foot><p>ART: antiretroviral therapy; ND: not determined; RCT: randomized controlled trial.</p><p><sup>a</sup> Countries were categorized as low-, middle- or high-income, as defined by the World Bank for 2014.<xref rid="R22" ref-type="bibr"><sup>22</sup></xref></p><p><sup>b</sup> Participants&#x02019; ages are given as a range or as a mean (standard deviation).</p><p><sup>c</sup> Whether or not the measure of the association between employment status and adherence to antiretroviral treatment was adjusted for major confounding variables.</p></table-wrap-foot></table-wrap><p>Twenty-seven studies, involving 8008 patients (92%), included participants who were already receiving ART. Twenty-three studies, involving 8171 patients (94%), defined adherence as receiving 95% or more of prescribed doses in a given period. In addition, 22 studies, involving 7755 patients (89%), used self-report questionnaires to assess adherence, whereas three used pharmacy refill data, one used the pill count, one used the blood drug concentration and one used a combination of methods. The median sample size was 300 participants (range: 46&#x02013;1016). When reported, the percentage of males ranged from 21.3% to 88.0% between studies. The median percentage of unemployed participants was 41% (range: 16&#x02013;79%) and the percentage of participants who adhered to ART ranged from 14.9% to 93.1%.</p><sec><title>Risk of bias</title><p>The results of our assessment of the risk of bias in all studies included in the meta-analysis are shown in <xref ref-type="fig" rid="F2">Fig.&#x000a0;2</xref>. The risk of bias in the selection of participants was low in all studies. However, the risk of selection bias due to inadequate confirmation or consideration of confounding variables was low in 16 studies but high in 12: 16 studies adjusted for major confounding variables during the analysis phase, whereas the remaining 12 reported unadjusted associations between employment status and adherence to ART. The risk of detection bias due to inadequate outcome assessment was low in the six studies that assessed adherence using objective measures and high in the remaining 22, which used self-report questionnaires. The risk of attrition bias due to inadequate outcome data handling was low in 24 studies, unclear in two and high in the two studies in which more than 20% of patients were lost to follow-up. The risk of selective reporting bias was low in all studies.</p><fig id="F2" fig-type="figure" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Risk of bias in studies in the meta-analysis of the association between employment status and adherence to antiretroviral therapy, 14 countries, 1996&#x02013;2014</p></caption><graphic xlink:href="BLT.14.138149-F2"/></fig></sec><sec><title>Association between adherence and employment</title><p>The strength of the association between being employed and adhering to ART reported in each study in low-, middle- and high-incomes countries is shown in <xref ref-type="fig" rid="F3">Fig.&#x000a0;3</xref>, <xref ref-type="fig" rid="F4">Fig.&#x000a0;4</xref> and <xref ref-type="fig" rid="F5">Fig.&#x000a0;5</xref>, respectively. The figures also give pooled estimates for the association in each income group. The pooled estimate for the OR in all countries was 1.27 (95% confidence interval, CI: 1.04&#x02013;1.55). There was evidence of substantial statistical heterogeneity between the results of all studies (<italic>I<sup>2</sup></italic>: 77%). The leave-one-study-out sensitivity analysis showed that no single study had an undue influence on the pooled estimate.</p><fig id="F3" fig-type="figure" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Association between being employed and adhering to antiretroviral therapy in studies from low-income countries, 2009&#x02013;2014</p></caption><p>CI: confidence interval; OR: odds ratio.</p><graphic xlink:href="BLT.14.138149-F3"/></fig><fig id="F4" fig-type="figure" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Association between being employed and adhering to antiretroviral therapy in studies from middle-income countries, 2004&#x02013;2014</p></caption><p>CI: confidence interval; OR: odds ratio.</p><graphic xlink:href="BLT.14.138149-F4"/></fig><fig id="F5" fig-type="figure" orientation="portrait" position="float"><label>Fig. 5</label><caption><p>Association between being employed and adhering to antiretroviral therapy in studies from high-income countries, 1996&#x02013;2013</p></caption><p>CI: confidence interval; OR: odds ratio.</p><graphic xlink:href="BLT.14.138149-F5"/></fig></sec><sec><title>Associations in subgroups</title><p>The magnitude and strength of the association between being employed and adhering to ART varied by country income group: it was highest in the seven studies from low-income countries, for which the pooled estimate for the OR was 1.85 (95% CI: 1.58&#x02013;2.18). In the 11 studies from middle-income countries, the association was not significant as the pooled estimate for the OR was&#x02009;0.94 (95% CI: 0.62&#x02013;1.42). However, the association was significant in the 10 studies from high-income countries: the pooled estimate for the OR was 1.33 (95% CI: 1.02&#x02013;1.74). In addition, the strength of the association was significantly higher in prospective cohort studies than in cross-sectional studies: the pooled OR was 2.05 (95% CI: 1.50&#x02013;2.81) and 1.17 (95% CI: 0.95&#x02013;1.44) for the two study types, respectively (<italic>P</italic>-value for interaction&#x02009;=&#x02009;0.003). The association was significant in studies that used an adherence threshold less than 100% (OR:&#x02009;1.59, 95% CI: 1.35&#x02013;1.87) but not in those that used a threshold of 100% (OR: 0.90, 95% CI: 0.64&#x02013;1.26; <italic>P</italic>-value for interaction&#x02009;=&#x02009;0.003). We also found that the type of adherence measure used did not significantly influence the association between being employed and adhering to ART: the pooled OR was 1.21 (95% CI: 0.98&#x02013;1.51) for studies that used self-report questionnaires compared with 1.67 (95% CI: 1.09&#x02013;2.56) for those that used other measures (<italic>P</italic>-value for interaction&#x02009;=&#x02009;0.19; <xref ref-type="table" rid="T2">Table&#x000a0;2</xref>).</p><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Association between being employed and adhering to antiretroviral therapy, by subgroup, 14 countries, 1996&#x02013;2014</title></caption><table frame="hsides" rules="groups"><col width="133" span="1"/><col width="53" span="1"/><col width="100" span="1"/><col width="41" span="1"/><col width="101" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Subgroup</th><th rowspan="2" valign="top" align="center" scope="col" colspan="1">No. of studies</th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">Pooled association<hr/></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1">Subgroup heterogeneity,<sup>a</sup>
<italic>P</italic></th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">OR (95% CI)</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><italic>I<sup>2</sup></italic>, %<sup>b</sup></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>Income group<sup>c</sup></bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.003</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Low</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="center" rowspan="1" colspan="1">1.85 (1.58&#x02013;2.18)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Middle</td><td valign="top" align="center" rowspan="1" colspan="1">11</td><td valign="top" align="center" rowspan="1" colspan="1">0.94 (0.62&#x02013;1.42)</td><td valign="top" align="center" rowspan="1" colspan="1">75</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">High</td><td valign="top" align="center" rowspan="1" colspan="1">10</td><td valign="top" align="center" rowspan="1" colspan="1">1.33 (1.02&#x02013;1.74)</td><td valign="top" align="center" rowspan="1" colspan="1">56</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>Study design</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.003</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Cross-sectional</td><td valign="top" align="center" rowspan="1" colspan="1">24</td><td valign="top" align="center" rowspan="1" colspan="1">1.17 (0.95&#x02013;1.44)</td><td valign="top" align="center" rowspan="1" colspan="1">77</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Prospective cohort</td><td valign="top" align="center" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">2.05 (1.50&#x02013;2.81)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>Adherence threshold</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.003</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x0003c;&#x02009;100%</td><td valign="top" align="center" rowspan="1" colspan="1">20</td><td valign="top" align="center" rowspan="1" colspan="1">1.59 (1.35&#x02013;1.87)</td><td valign="top" align="center" rowspan="1" colspan="1">17</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">100%</td><td valign="top" align="center" rowspan="1" colspan="1">8</td><td valign="top" align="center" rowspan="1" colspan="1">0.90 (0.64&#x02013;1.26)</td><td valign="top" align="center" rowspan="1" colspan="1">78</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>Adherence measure</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.19</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Self-report questionnaire</td><td valign="top" align="center" rowspan="1" colspan="1">22</td><td valign="top" align="center" rowspan="1" colspan="1">1.21 (0.98&#x02013;1.51)</td><td valign="top" align="center" rowspan="1" colspan="1">81</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Other</td><td valign="top" align="center" rowspan="1" colspan="1">6</td><td valign="top" align="center" rowspan="1" colspan="1">1.67 (1.09&#x02013;2.56)</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td></tr></tbody></table><table-wrap-foot><p>ART: antiretroviral therapy; CI: confidence interval; NA: not applicable; OR: odds ratio.</p><p><sup>a</sup> Subgroups were compared using the <italic>&#x003c7;<sup>2</sup></italic> test.</p><p><sup>b</sup>
<italic>I<sup>2</sup></italic> indicates the heterogeneity between the results of the studies in the subgroup.</p><p><sup>c</sup> Countries were categorized as low-, middle- or high-income, as defined by the World Bank for 2014.<xref rid="R22" ref-type="bibr"><sup>22</sup></xref></p></table-wrap-foot></table-wrap></sec><sec><title>Period and study size effects</title><p>The association between being employed and adhering to ART was observed to change over time, i.e. there was a period effect. The magnitude of the association declined with the publication year &#x02013; the pooled OR for studies published between 2011 and 2013 was lower than that for those reported before 2011 (<xref ref-type="fig" rid="F6">Fig.&#x000a0;6</xref>). Similarly, we found that study size also significantly influenced the association, which was more pronounced in those with small samples (<xref ref-type="fig" rid="F7">Fig.&#x000a0;7</xref>). For each additional 100 study participants, the magnitude of the association decreased by 9% (<italic>P</italic>&#x02009;=&#x02009;0.001).</p><fig id="F6" fig-type="figure" orientation="portrait" position="float"><label>Fig. 6</label><caption><p>Association between being employed and adhering to antiretroviral therapy, by study publication year, 14 countries, 1996&#x02013;2012</p></caption><p><sup>a</sup> The odds ratio represents the odds that an employed patient would adhere to treatment compared with an unemployed patient.</p><p><sup>b</sup> The area of each circle is in inverse proportion to the precision of the odds ratio.</p><graphic xlink:href="BLT.14.138149-F6"/></fig><fig id="F7" fig-type="figure" orientation="portrait" position="float"><label>Fig. 7</label><caption><p>Association between being employed and adhering to antiretroviral therapy, by study sample size, 14 countries, 1996&#x02013;2012</p></caption><p><sup>a</sup> The odds ratio represents the odds that an employed patient would adhere to treatment compared with an unemployed patient.</p><p><sup>b</sup> The area of each circle is in inverse proportion to the precision of the odds ratio.</p><graphic xlink:href="BLT.14.138149-F7"/></fig></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Overall, we found that patients with HIV infections who were employed were 27% more likely to adhere to ART than those who were unemployed. This is in agreement with the results of our previous meta-analysis<xref rid="R19" ref-type="bibr"><sup>19</sup></xref> and of others<xref rid="R5" ref-type="bibr"><sup>5</sup></xref> who reported that one of the barriers to ART adherence in both developed and developing countries was financial constraints, which may be considered a proxy for unemployment. One difference from our previous report is that the magnitude and strength of the association between being employed and adhering to ART were highest in studies from low-income countries. Hence, unemployment may have a greater effect on ART adherence in these settings.</p><p>It is possible that employment facilitates adherence to HIV treatment because it is associated with, for example, increased social support, better structuring of time and improved psychosocial well-being &#x02013; these associations have all been documented in the general population.<xref rid="R54" ref-type="bibr"><sup>54</sup></xref><sup>,</sup><xref rid="R55" ref-type="bibr"><sup>55</sup></xref> A review of 16 longitudinal studies showed evidence that unemployment has a negative effect on mental health<xref rid="R56" ref-type="bibr"><sup>56</sup></xref> and other studies have found that depression and impaired psychosocial well-being are associated with poor ART adherence.<xref rid="R57" ref-type="bibr"><sup>57</sup></xref> Employment may also promote increased material well-being, for example, by improving food security and housing quality and by reducing poverty &#x02013; all three are known to be associated with adherence to HIV treatment.<xref rid="R5" ref-type="bibr"><sup>5</sup></xref><sup>,</sup><xref rid="R58" ref-type="bibr"><sup>58</sup></xref><sup>,</sup><xref rid="R59" ref-type="bibr"><sup>59</sup></xref> In addition, employment may promote adherence to ART by improving access to medical services through employer-sponsored health programmes that specifically encourage HIV treatment and by having a positive effect on physical and mental health-related quality of life.<xref rid="R5" ref-type="bibr"><sup>5</sup></xref><sup>,</sup><xref rid="R60" ref-type="bibr"><sup>60</sup></xref> Conversely, the association may, in part, be due to the positive effect of ART on an individual&#x02019;s ability to find and retain employment, i.e. reverse causation. For example, it was found that HIV-infected workers who were not receiving ART were almost twice as likely to report being unable to work in the previous week than those who recently began and were adherent to ART.<xref rid="R61" ref-type="bibr"><sup>61</sup></xref> Another study on more than 2000 HIV-infected adults enrolled in an ART programme estimated that four&#x000a0;years after ART initiation, employment had returned to about 90% of the rates observed in the same patients three to five&#x000a0;years before ART initiation.<xref rid="R62" ref-type="bibr"><sup>62</sup></xref> Further prospective, longitudinal, cohort studies of employment status, ART adherence and other factors could help tease out the relative effects of ART adherence and employment on each other.</p><p>Despite mutual reinforcement between employment and ART adherence, it can be difficult for individuals to maintain adherence. For example, it was found that the main reasons for the discontinuation of antiretroviral therapy in the workplace in South Africa were: individuals being uncertain about their own HIV status and about the value of ART; poor relationships between patients and health-care providers; and discrimination in the workplace.<xref rid="R63" ref-type="bibr"><sup>63</sup></xref> Furthermore, workplace participants also felt that the follow-up visits required by ART clinics created problems for them with their employers. The most frequently cited reason for treatment discontinuation among these individuals was harassment and discrimination by line managers who refused to grant time off from work for clinic attendance. For public sector employees, the main reasons included relocation away from HIV care providers and having insufficient money for transportation to clinical facilities.<xref rid="R63" ref-type="bibr"><sup>63</sup></xref> These findings suggest there is a considerable need to promote awareness of the importance of ART adherence and to develop employment arrangements among both employers and employees that encourage adherence.</p><sec><title>Adherence, employment and gender</title><p>Unexpectedly, we found no evidence that gender had a significant influence on the association between employment status and ART adherence. Several factors could account for this finding. There is a gender gap in access to antiretroviral therapy. In most areas of the world, and especially in settings with a high burden of HIV infection, women are more likely than men to access both ART and supportive HIV services, such as targeted counselling and programmes for the prevention of mother-to-child HIV transmission offered by antenatal services.<xref rid="R64" ref-type="bibr"><sup>64</sup></xref> Conversely, men may have better access to employment than women and employment could facilitate increased adherence among men.<xref rid="R65" ref-type="bibr"><sup>65</sup></xref><sup>,</sup><xref rid="R66" ref-type="bibr"><sup>66</sup></xref></p></sec><sec><title>Period effect</title><p>Our finding that the association between being employed and adhering to ART declined over time may reflect changes in ART regimens, such as the trend towards once-daily dosing, reductions in the pill burden and side-effects,<xref rid="R67" ref-type="bibr"><sup>67</sup></xref><sup>,</sup><xref rid="R68" ref-type="bibr"><sup>68</sup></xref> better access to treatment for both employed and unemployed individuals or a drop in the cost of HIV medications.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref> Further research is needed to determine whether this finding is specific to the studies we included or whether it signifies a true decrease in the association over time.</p></sec><sec><title>Limitations</title><p>The findings of this meta-analysis should be interpreted with caution. The observational nature of the data &#x02013; 85% of the studies included had a cross-sectional design &#x02013; limited our ability to draw causal inferences and our findings may be affected by reverse causation bias or by other unknown confounding factors that were not adjusted for. Additionally, we found significant heterogeneity across the studies, which suggests that a substantial percentage of the variability in effect estimates was due to heterogeneity rather than to sampling errors, i.e. to chance. Much of the heterogeneity observed may be explained by differences in the adherence threshold, study sample size and study design. Nevertheless, even when there is substantial heterogeneity, meta-analysis is regarded as preferable for data synthesis to qualitative or narrative interpretation since these approaches can lead to misleading conclusions that should not be generalized beyond the scope of the analysis.<xref rid="R69" ref-type="bibr"><sup>69</sup></xref> The ability to draw conclusions from quantitative data is an important feature of meta-analyses and its absence is one reason for avoiding narrative interpretations without a data synthesis. It is worth noting that the heterogeneity observed in the current study appears to be the norm rather than the exception in meta-analyses of ART adherence.<xref rid="R14" ref-type="bibr"><sup>14</sup></xref><sup>,</sup><xref rid="R15" ref-type="bibr"><sup>15</sup></xref> An additional potential limitation is that none of the studies included compared treatment adherence across different types of occupation. Further, we found evidence for a small study effect and it is possible that the observed magnitude of the association between being employed and adhering to ART could have been inflated by studies with small sample sizes.</p><p>Despite these limitations, our study had important strengths. We conducted comprehensive searches of databases to ensure that all relevant, published studies were identified. We also carried out meta-regression analyses to determine whether any particular study-level factor explained the results or could account for the observed variations between studies. In performing this comprehensive and robust review of the existing literature, we identified gaps in the current literature on determinants of ART adherence.</p></sec><sec><title>Areas for future research</title><p>Our review was unable to address all pertinent questions on the association between employment status and optimal adherence to HIV treatment. Our study findings indicate a need for a range of further research: (i)&#x000a0;to investigate mechanisms by which employment and ART adherence affect each other; (ii)&#x000a0;to determine how different types of employment can differentially influence ART adherence; (iii)&#x000a0;to study the association and interaction between employment and adherence to medications for chronic comorbid diseases, e.g. hypertension, diabetes and asthma in HIV-infected or uninfected individuals; (iv)&#x000a0;to conduct interventional studies of how employment-creation programmes can positively influence HIV treatment adherence, disease progression and quality of life; and (v)&#x000a0;to carry out cost-benefit and cost-effectiveness analyses of selected employment-creation interventions for people living with HIV.</p></sec></sec></body><back><ack><title>Acknowledgements</title><p>We thank Meg Doherty, Eyerusalem Kebede Negussie and Caroline Connor.</p></ack><fn-group><title>Funding:</title><fn fn-type="supported-by"><p>Funding was provided by the HIV/AIDS and the World of Work Branch (ILOAIDS) of the International Labour Organization.</p></fn></fn-group><fn-group><title>Competing interests:</title><fn fn-type="financial-disclosure"><p>None declared.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><mixed-citation publication-type="book">Global update on HIV treatment 2013: results, impact and opportunities. Geneva; World Health Organization; 2013. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2013/20130630_treatment_report_summary_en.pdf">http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2013/20130630_treatment_report_summary_en.pdf</ext-link> [cited 2014 Oct 17].</mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="journal"><string-name><surname>Mills</surname>
<given-names>EJ</given-names></string-name>, <string-name><surname>Nachega</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>Buchan</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Orbinski</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Attaran</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Singh</surname>
<given-names>S</given-names></string-name>, <etal>et al.</etal><article-title>Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis.</article-title><source>JAMA</source>. <year>2006</year>;<volume>296</volume>(<issue>6</issue>):<fpage>679</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1001/jama.296.6.679</pub-id><pub-id pub-id-type="pmid">16896111</pub-id></mixed-citation></ref><ref id="R3"><label>3</label><mixed-citation publication-type="journal"><string-name><surname>Ortego</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Huedo-Medina</surname>
<given-names>TB</given-names></string-name>, <string-name><surname>Llorca</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Sevilla</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Santos</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Rodr&#x000ed;guez</surname>
<given-names>E</given-names></string-name>, <etal>et al.</etal><article-title>Adherence to highly active antiretroviral therapy (HAART): a meta-analysis.</article-title><source>AIDS Behav</source>. <year>2011</year>;<volume>15</volume>(<issue>7</issue>):<fpage>1381</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1007/s10461-011-9942-x</pub-id><pub-id pub-id-type="pmid">21468660</pub-id></mixed-citation></ref><ref id="R4"><label>4</label><mixed-citation publication-type="journal"><string-name><surname>Juday</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Gupta</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Grimm</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Wagner</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>E</given-names></string-name>. <article-title>Factors associated with complete adherence to HIV combination antiretroviral therapy.</article-title><source>HIV Clin Trials</source>. <year>2011</year>;<volume>12</volume>(<issue>2</issue>):<fpage>71</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1310/hct1202-71</pub-id><pub-id pub-id-type="pmid">21498150</pub-id></mixed-citation></ref><ref id="R5"><label>5</label><mixed-citation publication-type="journal"><string-name><surname>Mills</surname>
<given-names>EJ</given-names></string-name>, <string-name><surname>Nachega</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>Bangsberg</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Singh</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Rachlis</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>P</given-names></string-name>, <etal>et al.</etal><article-title>Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators.</article-title><source>PLoS Med</source>. <year>2006</year>;<volume>3</volume>(<issue>11</issue>):<fpage>e438</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pmed.0030438</pub-id><pub-id pub-id-type="pmid">17121449</pub-id></mixed-citation></ref><ref id="R6"><label>6</label><mixed-citation publication-type="journal"><string-name><surname>Bangsberg</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Perry</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Charlebois</surname>
<given-names>ED</given-names></string-name>, <string-name><surname>Clark</surname>
<given-names>RA</given-names></string-name>, <string-name><surname>Roberston</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Zolopa</surname>
<given-names>AR</given-names></string-name>, <etal>et al.</etal><article-title>Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.</article-title><source>AIDS</source>. <year>2001</year>;<volume>15</volume>(<issue>9</issue>):<fpage>1181</fpage>&#x02013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1097/00002030-200106150-00015</pub-id><pub-id pub-id-type="pmid">11416722</pub-id></mixed-citation></ref><ref id="R7"><label>7</label><mixed-citation publication-type="journal"><string-name><surname>Clavel</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Hance</surname>
<given-names>AJ</given-names></string-name>. <article-title>HIV drug resistance.</article-title><source>N Engl J Med</source>. <year>2004</year>;<volume>350</volume>(<issue>10</issue>):<fpage>1023</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra025195</pub-id><pub-id pub-id-type="pmid">14999114</pub-id></mixed-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="journal"><string-name><surname>Nachega</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>Hislop</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Dowdy</surname>
<given-names>DW</given-names></string-name>, <string-name><surname>Chaisson</surname>
<given-names>RE</given-names></string-name>, <string-name><surname>Regensberg</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Maartens</surname>
<given-names>G</given-names></string-name>. <article-title>Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes.</article-title><source>Ann Intern Med</source>. <year>2007</year>;<volume>146</volume>(<issue>8</issue>):<fpage>564</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.7326/0003-4819-146-8-200704170-00007</pub-id><pub-id pub-id-type="pmid">17438315</pub-id></mixed-citation></ref><ref id="R9"><label>9</label><mixed-citation publication-type="journal"><string-name><surname>Nachega</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>Hislop</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Dowdy</surname>
<given-names>DW</given-names></string-name>, <string-name><surname>Lo</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Omer</surname>
<given-names>SB</given-names></string-name>, <string-name><surname>Regensberg</surname>
<given-names>L</given-names></string-name>, <etal>et al.</etal><article-title>Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults.</article-title><source>J Acquir Immune Defic Syndr</source>. <year>2006</year>;<volume>43</volume>(<issue>1</issue>):<fpage>78</fpage>&#x02013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1097/01.qai.0000225015.43266.46</pub-id><pub-id pub-id-type="pmid">16878045</pub-id></mixed-citation></ref><ref id="R10"><label>10</label><mixed-citation publication-type="journal"><string-name><surname>Baggaley</surname>
<given-names>RF</given-names></string-name>, <string-name><surname>White</surname>
<given-names>RG</given-names></string-name>, <string-name><surname>Hollingsworth</surname>
<given-names>TD</given-names></string-name>, <string-name><surname>Boily</surname>
<given-names>MC</given-names></string-name>. <article-title>Heterosexual HIV-1 infectiousness and antiretroviral use: systematic review of prospective studies of discordant couples.</article-title><source>Epidemiology</source>. <year>2013</year>;<volume>24</volume>(<issue>1</issue>):<fpage>110</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1097/EDE.0b013e318276cad7</pub-id><pub-id pub-id-type="pmid">23222513</pub-id></mixed-citation></ref><ref id="R11"><label>11</label><mixed-citation publication-type="journal"><string-name><surname>Cohen</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>YQ</given-names></string-name>, <string-name><surname>McCauley</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Gamble</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Hosseinipour</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Kumarasamy</surname>
<given-names>N</given-names></string-name>, <etal>et al.</etal>; <collab>HPTN 052 Study Team</collab>. <article-title>Prevention of HIV-1 infection with early antiretroviral therapy.</article-title><source>N Engl J Med</source>. <year>2011</year>;<volume>365</volume>(<issue>6</issue>):<fpage>493</fpage>&#x02013;<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1105243</pub-id><pub-id pub-id-type="pmid">21767103</pub-id></mixed-citation></ref><ref id="R12"><label>12</label><mixed-citation publication-type="journal"><string-name><surname>Nachega</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>Leisegang</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Bishai</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Nguyen</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Hislop</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Cleary</surname>
<given-names>S</given-names></string-name>, <etal>et al.</etal><article-title>Association of antiretroviral therapy adherence and health care costs.</article-title><source>Ann Intern Med</source>. <year>2010</year>;<volume>152</volume>(<issue>1</issue>):<fpage>18</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.7326/0003-4819-152-1-201001050-00006</pub-id><pub-id pub-id-type="pmid">20048268</pub-id></mixed-citation></ref><ref id="R13"><label>13</label><mixed-citation publication-type="journal"><string-name><surname>Liu</surname>
<given-names>GG</given-names></string-name>, <string-name><surname>Guo</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>SR</given-names></string-name>. <article-title>Economic costs to business of the HIV/AIDS epidemic.</article-title><source>Pharmacoeconomics</source>. <year>2004</year>;<volume>22</volume>(<issue>18</issue>):<fpage>1181</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.2165/00019053-200422180-00003</pub-id><pub-id pub-id-type="pmid">15606225</pub-id></mixed-citation></ref><ref id="R14"><label>14</label><mixed-citation publication-type="journal"><string-name><surname>Falagas</surname>
<given-names>ME</given-names></string-name>, <string-name><surname>Zarkadoulia</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Pliatsika</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Panos</surname>
<given-names>G</given-names></string-name>. <article-title>Socioeconomic status (SES) as a determinant of adherence to treatment in HIV infected patients: a systematic review of the literature.</article-title><source>Retrovirology</source>. <year>2008</year>;<volume>5</volume>(<issue>1</issue>):<fpage>13</fpage>. <pub-id pub-id-type="doi">10.1186/1742-4690-5-13</pub-id><pub-id pub-id-type="pmid">18241330</pub-id></mixed-citation></ref><ref id="R15"><label>15</label><mixed-citation publication-type="journal"><string-name><surname>Peltzer</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Pengpid</surname>
<given-names>S</given-names></string-name>. <article-title>Socioeconomic factors in adherence to HIV therapy in low- and middle-income countries.</article-title><source>J Health Popul Nutr</source>. <year>2013</year>;<volume>31</volume>(<issue>2</issue>):<fpage>150</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.3329/jhpn.v31i2.16379</pub-id><pub-id pub-id-type="pmid">23930333</pub-id></mixed-citation></ref><ref id="R16"><label>16</label><mixed-citation publication-type="journal"><string-name><surname>Atkinson</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Petrozzino</surname>
<given-names>JJ</given-names></string-name>. <article-title>An evidence-based review of treatment-related determinants of patients&#x02019; nonadherence to HIV medications.</article-title><source>AIDS Patient Care STDS</source>. <year>2009</year>;<volume>23</volume>(<issue>11</issue>):<fpage>903</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1089/apc.2009.0024</pub-id><pub-id pub-id-type="pmid">19642921</pub-id></mixed-citation></ref><ref id="R17"><label>17</label><mixed-citation publication-type="journal"><string-name><surname>Arrivillaga</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ross</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Useche</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Alzate</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Correa</surname>
<given-names>D</given-names></string-name>. <article-title>Social position, gender role, and treatment adherence among Colombian women living with HIV/AIDS: social determinants of health approach.</article-title><source>Rev Panam Salud Publica</source>. <year>2009</year>;<volume>26</volume>(<issue>6</issue>):<fpage>502</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1590/S1020-49892009001200005</pub-id><pub-id pub-id-type="pmid">20107704</pub-id></mixed-citation></ref><ref id="R18"><label>18</label><mixed-citation publication-type="journal"><string-name><surname>Berg</surname>
<given-names>KM</given-names></string-name>, <string-name><surname>Demas</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Howard</surname>
<given-names>AA</given-names></string-name>, <string-name><surname>Schoenbaum</surname>
<given-names>EE</given-names></string-name>, <string-name><surname>Gourevitch</surname>
<given-names>MN</given-names></string-name>, <string-name><surname>Arnsten</surname>
<given-names>JH</given-names></string-name>. <article-title>Gender differences in factors associated with adherence to antiretroviral therapy.</article-title><source>J Gen Intern Med</source>. <year>2004</year>;<volume>19</volume>(<issue>11</issue>):<fpage>1111</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/j.1525-1497.2004.30445.x</pub-id><pub-id pub-id-type="pmid">15566440</pub-id></mixed-citation></ref><ref id="R19"><label>19</label><mixed-citation publication-type="book">Nachega JB, Uthman OA, Mills EJ, Peltzer K, Amekudzi K, Ouedraogo A. The impact of employment on HIV treatment adherence. Geneva: International Labour Organization; 2013. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ilo.org/wcmsp5/groups/public/---ed_protect/---protrav/---ilo_aids/documents/publication/wcms_230625.pdf">http://www.ilo.org/wcmsp5/groups/public/---ed_protect/---protrav/---ilo_aids/documents/publication/wcms_230625.pdf</ext-link> [cited 2014 Sep 21].</mixed-citation></ref><ref id="R20"><label>20</label><mixed-citation publication-type="journal"><string-name><surname>Moher</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Liberati</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Tetzlaff</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Altman</surname>
<given-names>DG</given-names></string-name>; <collab>PRISMA Group</collab>. <article-title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.</article-title><source>PLoS Med</source>. <year>2009</year>;<volume>6</volume>(<issue>7</issue>):<fpage>e1000097</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1000097</pub-id><pub-id pub-id-type="pmid">19621072</pub-id></mixed-citation></ref><ref id="R21"><label>21</label><mixed-citation publication-type="journal"><string-name><surname>Kim</surname>
<given-names>SY</given-names></string-name>, <string-name><surname>Park</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>YJ</given-names></string-name>, <string-name><surname>Seo</surname>
<given-names>HJ</given-names></string-name>, <string-name><surname>Sheen</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>Hahn</surname>
<given-names>S</given-names></string-name>, <etal>et al.</etal><article-title>Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity.</article-title><source>J Clin Epidemiol</source>. <year>2013</year>;<volume>66</volume>(<issue>4</issue>):<fpage>408</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.jclinepi.2012.09.016</pub-id><pub-id pub-id-type="pmid">23337781</pub-id></mixed-citation></ref><ref id="R22"><label>22</label><mixed-citation publication-type="web">Country and Lending Groups [Internet]. Washington: World Bank; 2014. Available from: <ext-link ext-link-type="uri" xlink:href="http://data.worldbank.org/about/country-and-lending-groups">http://data.worldbank.org/about/country-and-lending-groups</ext-link> [cited 2014 Sep 20].</mixed-citation></ref><ref id="R23"><label>23</label><mixed-citation publication-type="book"><source>Current international recommendations on labour statistics.</source><publisher-loc>Geneva</publisher-loc>: <publisher-name>International Labour Office</publisher-name>; <year>2000</year>.</mixed-citation></ref><ref id="R24"><label>24</label><mixed-citation publication-type="journal"><string-name><surname>Galobardes</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Shaw</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lawlor</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Lynch</surname>
<given-names>JW</given-names></string-name>, <string-name><surname>Davey Smith</surname>
<given-names>G</given-names></string-name>. <article-title>Indicators of socioeconomic position (part 1).</article-title><source>J Epidemiol Community Health</source>. <year>2006</year>;<volume>60</volume>(<issue>1</issue>):<fpage>7</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1136/jech.2004.023531</pub-id><pub-id pub-id-type="pmid">16361448</pub-id></mixed-citation></ref><ref id="R25"><label>25</label><mixed-citation publication-type="journal"><string-name><surname>DerSimonian</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Laird</surname>
<given-names>N</given-names></string-name>. <article-title>Meta-analysis in clinical trials.</article-title><source>Control Clin Trials</source>. <year>1986</year>;<volume>7</volume>(<issue>3</issue>):<fpage>177</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1016/0197-2456(86)90046-2</pub-id><pub-id pub-id-type="pmid">3802833</pub-id></mixed-citation></ref><ref id="R26"><label>26</label><mixed-citation publication-type="journal"><string-name><surname>Normand</surname>
<given-names>SL</given-names></string-name>. <article-title>Meta-analysis: formulating, evaluating, combining, and reporting.</article-title><source>Stat Med</source>. <year>1999</year>;<volume>18</volume>(<issue>3</issue>):<fpage>321</fpage>&#x02013;<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1097-0258(19990215)18:3&#x0003c;321::AID-SIM28&#x0003e;3.0.CO;2-P</pub-id><pub-id pub-id-type="pmid">10070677</pub-id></mixed-citation></ref><ref id="R27"><label>27</label><mixed-citation publication-type="journal"><string-name><surname>Singh</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Squier</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Sivek</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Wagener</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Nguyen</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>Yu</surname>
<given-names>VL</given-names></string-name>. <article-title>Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance.</article-title><source>AIDS Care</source>. <year>1996</year>;<volume>8</volume>(<issue>3</issue>):<fpage>261</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1080/09540129650125696</pub-id><pub-id pub-id-type="pmid">8827119</pub-id></mixed-citation></ref><ref id="R28"><label>28</label><mixed-citation publication-type="journal"><string-name><surname>Singh</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Berman</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Swindells</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Justis</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Mohr</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Squier</surname>
<given-names>C</given-names></string-name>, <etal>et al.</etal><article-title>Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy.</article-title><source>Clin Infect Dis</source>. <year>1999</year>;<volume>29</volume>(<issue>4</issue>):<fpage>824</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1086/520443</pub-id><pub-id pub-id-type="pmid">10589897</pub-id></mixed-citation></ref><ref id="R29"><label>29</label><mixed-citation publication-type="journal"><string-name><surname>Duong</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Piroth</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Grappin</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Forte</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Peytavin</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Buisson</surname>
<given-names>M</given-names></string-name>, <etal>et al.</etal><article-title>Evaluation of the Patient Medication Adherence Questionnaire as a tool for self-reported adherence assessment in HIV-infected patients on antiretroviral regimens.</article-title><source>HIV Clin Trials</source>. <year>2001</year>;<volume>2</volume>(<issue>2</issue>):<fpage>128</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1310/M3JR-G390-LXCM-F62G</pub-id><pub-id pub-id-type="pmid">11590521</pub-id></mixed-citation></ref><ref id="R30"><label>30</label><mixed-citation publication-type="journal"><string-name><surname>Ickovics</surname>
<given-names>JR</given-names></string-name>, <string-name><surname>Cameron</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Zackin</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Bassett</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Chesney</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Johnson</surname>
<given-names>VA</given-names></string-name>, <etal>et al.</etal>; <collab>Adult AIDS Clinical Trials Group 370 Protocol Team</collab>. <article-title>Consequences and determinants of adherence to antiretroviral medication: results from Adult AIDS Clinical Trials Group protocol 370.</article-title><source>Antivir Ther</source>. <year>2002</year>;<volume>7</volume>(<issue>3</issue>):<fpage>185</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="pmid">12487386</pub-id></mixed-citation></ref><ref id="R31"><label>31</label><mixed-citation publication-type="journal"><string-name><surname>Nachega</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>Stein</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Lehman</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Hlatshwayo</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Mothopeng</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Chaisson</surname>
<given-names>RE</given-names></string-name>, <etal>et al.</etal><article-title>Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa.</article-title><source>AIDS Res Hum Retroviruses</source>. <year>2004</year>;<volume>20</volume>(<issue>10</issue>):<fpage>1053</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1089/aid.2004.20.1053</pub-id><pub-id pub-id-type="pmid">15585095</pub-id></mixed-citation></ref><ref id="R32"><label>32</label><mixed-citation publication-type="journal"><string-name><surname>Beyene</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Gedif</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Gebre-Mariam</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Engidawork</surname>
<given-names>E</given-names></string-name>. <article-title>Highly active antiretroviral therapy adherence and its determinants in selected hospitals from south and central Ethiopia.</article-title><source>Pharmacoepidemiol Drug Saf</source>. <year>2009</year>;<volume>18</volume>(<issue>11</issue>):<fpage>1007</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1002/pds.1814</pub-id><pub-id pub-id-type="pmid">19650153</pub-id></mixed-citation></ref><ref id="R33"><label>33</label><mixed-citation publication-type="journal"><string-name><surname>Duggan</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Locher</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Fink</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Okonta</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Chakraborty</surname>
<given-names>J</given-names></string-name>. <article-title>Adherence to antiretroviral therapy: a survey of factors associated with medication usage.</article-title><source>AIDS Care</source>. <year>2009</year>;<volume>21</volume>(<issue>9</issue>):<fpage>1141</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1080/09540120902730039</pub-id><pub-id pub-id-type="pmid">20024773</pub-id></mixed-citation></ref><ref id="R34"><label>34</label><mixed-citation publication-type="journal"><string-name><surname>Nakimuli-Mpungu</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Mutamba</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Othengo</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Musisi</surname>
<given-names>S</given-names></string-name>. <article-title>Psychological distress and adherence to highly active anti-retroviral therapy (HAART) in Uganda: a pilot study.</article-title><source>Afr Health Sci</source>. <year>2009</year>;<volume>9</volume><issue>Suppl 1</issue>:<fpage>S2</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">20589156</pub-id></mixed-citation></ref><ref id="R35"><label>35</label><mixed-citation publication-type="journal"><string-name><surname>Campos</surname>
<given-names>LN</given-names></string-name>, <string-name><surname>Guimar&#x000e3;es</surname>
<given-names>MD</given-names></string-name>, <string-name><surname>Remien</surname>
<given-names>RH</given-names></string-name>. <article-title>Anxiety and depression symptoms as risk factors for non-adherence to antiretroviral therapy in Brazil.</article-title><source>AIDS Behav</source>. <year>2010</year>;<volume>14</volume>(<issue>2</issue>):<fpage>289</fpage>&#x02013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1007/s10461-008-9435-8</pub-id><pub-id pub-id-type="pmid">18648925</pub-id></mixed-citation></ref><ref id="R36"><label>36</label><mixed-citation publication-type="journal"><string-name><surname>Giday</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Shiferaw</surname>
<given-names>W</given-names></string-name>. <article-title>Factors affecting adherence of antiretroviral treatment among AIDS patients in an Ethiopian tertiary university teaching hospital.</article-title><source>Ethiop Med J</source>. <year>2010</year>;<volume>48</volume>(<issue>3</issue>):<fpage>187</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="pmid">21073079</pub-id></mixed-citation></ref><ref id="R37"><label>37</label><mixed-citation publication-type="journal"><string-name><surname>Kunutsor</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Walley</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Katabira</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Muchuro</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Balidawa</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Namagala</surname>
<given-names>E</given-names></string-name>, <etal>et al.</etal><article-title>Clinic attendance for medication refills and medication adherence amongst an antiretroviral treatment cohort in Uganda: a prospective study.</article-title><source>Aids Res Treat</source>. <year>2010</year>;<volume>2010</volume>:<fpage>872396</fpage>. <pub-id pub-id-type="doi">10.1155/2010/872396</pub-id><pub-id pub-id-type="pmid">21490907</pub-id></mixed-citation></ref><ref id="R38"><label>38</label><mixed-citation publication-type="journal"><string-name><surname>Lal</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Kant</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Dewan</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Rai</surname>
<given-names>SK</given-names></string-name>, <string-name><surname>Biswas</surname>
<given-names>A</given-names></string-name>. <article-title>A two-site hospital-based study on factors associated with nonadherence to highly active antiretroviral therapy.</article-title><source>Indian J Public Health</source>. <year>2010</year>;<volume>54</volume>(<issue>4</issue>):<fpage>179</fpage>&#x02013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.4103/0019-557X.77256</pub-id><pub-id pub-id-type="pmid">21372363</pub-id></mixed-citation></ref><ref id="R39"><label>39</label><mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>SJ</given-names></string-name>, <string-name><surname>Wen</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Wan</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Jiraphongsa</surname>
<given-names>C</given-names></string-name>. <article-title>Antiretroviral therapy adherence among patients living with HIV/AIDS in Thailand.</article-title><source>Nurs Health Sci</source>. <year>2010</year>;<volume>12</volume>(<issue>2</issue>):<fpage>212</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1111/j.1442-2018.2010.00521.x</pub-id><pub-id pub-id-type="pmid">20602694</pub-id></mixed-citation></ref><ref id="R40"><label>40</label><mixed-citation publication-type="journal"><string-name><surname>Peltzer</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Friend-du Preez</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Ramlagan</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Anderson</surname>
<given-names>J</given-names></string-name>. <article-title>Antiretroviral treatment adherence among HIV patients in KwaZulu-Natal, South Africa.</article-title><source>BMC Public Health</source>. <year>2010</year>;<volume>10</volume>(<issue>1</issue>):<fpage>111</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2458-10-111</pub-id><pub-id pub-id-type="pmid">20205721</pub-id></mixed-citation></ref><ref id="R41"><label>41</label><mixed-citation publication-type="journal"><string-name><surname>Sherr</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Lampe</surname>
<given-names>FC</given-names></string-name>, <string-name><surname>Clucas</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Johnson</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Fisher</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Leake Date</surname>
<given-names>H</given-names></string-name>, <etal>et al.</etal><article-title>Self-reported non-adherence to ART and virological outcome in a multiclinic UK study.</article-title><source>AIDS Care</source>. <year>2010</year>;<volume>22</volume>(<issue>8</issue>):<fpage>939</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1080/09540121.2010.482126</pub-id><pub-id pub-id-type="pmid">20574863</pub-id></mixed-citation></ref><ref id="R42"><label>42</label><mixed-citation publication-type="journal"><string-name><surname>Venkatesh</surname>
<given-names>KK</given-names></string-name>, <string-name><surname>Srikrishnan</surname>
<given-names>AK</given-names></string-name>, <string-name><surname>Mayer</surname>
<given-names>KH</given-names></string-name>, <string-name><surname>Kumarasamy</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Raminani</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Thamburaj</surname>
<given-names>E</given-names></string-name>, <etal>et al.</etal><article-title>Predictors of nonadherence to highly active antiretroviral therapy among HIV-infected South Indians in clinical care: implications for developing adherence interventions in resource-limited settings.</article-title><source>AIDS Patient Care STDS</source>. <year>2010</year>;<volume>24</volume>(<issue>12</issue>):<fpage>795</fpage>&#x02013;<lpage>803</lpage>. <pub-id pub-id-type="doi">10.1089/apc.2010.0153</pub-id><pub-id pub-id-type="pmid">21091232</pub-id></mixed-citation></ref><ref id="R43"><label>43</label><mixed-citation publication-type="journal"><string-name><surname>Harris</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Pillinger</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Fromstein</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Gomez</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Garris</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Kanetsky</surname>
<given-names>PA</given-names></string-name>, <etal>et al.</etal><article-title>Risk factors for medication non-adherence in an HIV infected population in the Dominican Republic.</article-title><source>AIDS Behav</source>. <year>2011</year>;<volume>15</volume>(<issue>7</issue>):<fpage>1410</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1007/s10461-010-9781-1</pub-id><pub-id pub-id-type="pmid">20721615</pub-id></mixed-citation></ref><ref id="R44"><label>44</label><mixed-citation publication-type="journal"><string-name><surname>Kyser</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Buchacz</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Bush</surname>
<given-names>TJ</given-names></string-name>, <string-name><surname>Conley</surname>
<given-names>LJ</given-names></string-name>, <string-name><surname>Hammer</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Henry</surname>
<given-names>K</given-names></string-name>, <etal>et al.</etal><article-title>Factors associated with non-adherence to antiretroviral therapy in the SUN study.</article-title><source>AIDS Care</source>. <year>2011</year>;<volume>23</volume>(<issue>5</issue>):<fpage>601</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1080/09540121.2010.525603</pub-id><pub-id pub-id-type="pmid">21293992</pub-id></mixed-citation></ref><ref id="R45"><label>45</label><mixed-citation publication-type="journal"><string-name><surname>Wakibi</surname>
<given-names>SN</given-names></string-name>, <string-name><surname>Ng&#x02019;ang&#x02019;a</surname>
<given-names>ZW</given-names></string-name>, <string-name><surname>Mbugua</surname>
<given-names>GG</given-names></string-name>. <article-title>Factors associated with non-adherence to highly active antiretroviral therapy in Nairobi, Kenya.</article-title><source>AIDS Res Ther</source>. <year>2011</year>;<volume>8</volume>(<issue>1</issue>):<fpage>43</fpage>. <pub-id pub-id-type="doi">10.1186/1742-6405-8-43</pub-id><pub-id pub-id-type="pmid">22141425</pub-id></mixed-citation></ref><ref id="R46"><label>46</label><mixed-citation publication-type="journal"><string-name><surname>King</surname>
<given-names>RM</given-names></string-name>, <string-name><surname>Vidrine</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Danysh</surname>
<given-names>HE</given-names></string-name>, <string-name><surname>Fletcher</surname>
<given-names>FE</given-names></string-name>, <string-name><surname>McCurdy</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Arduino</surname>
<given-names>RC</given-names></string-name>, <etal>et al.</etal><article-title>Factors associated with nonadherence to antiretroviral therapy in HIV-positive smokers.</article-title><source>AIDS Patient Care STDS</source>. <year>2012</year>;<volume>26</volume>(<issue>8</issue>):<fpage>479</fpage>&#x02013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1089/apc.2012.0070</pub-id><pub-id pub-id-type="pmid">22612468</pub-id></mixed-citation></ref><ref id="R47"><label>47</label><mixed-citation publication-type="journal"><string-name><surname>Kitshoff</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Campbell</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Naidoo</surname>
<given-names>SS</given-names></string-name>. <article-title>The association between depression and adherence to antiretroviral therapy in HIV-positive patients, KwaZulu-Natal, South Africa.</article-title><source>S Afr Fam Pract</source>. <year>2012</year>;<volume>54</volume>(<issue>2</issue>):<fpage>145</fpage>&#x02013;<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1080/20786204.2012.10874194</pub-id></mixed-citation></ref><ref id="R48"><label>48</label><mixed-citation publication-type="journal"><string-name><surname>Berhe</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Tegabu</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Alemayehu</surname>
<given-names>M</given-names></string-name>. <article-title>Effect of nutritional factors on adherence to antiretroviral therapy among HIV-infected adults: a case control study in Northern Ethiopia.</article-title><source>BMC Infect Dis</source>. <year>2013</year>;<volume>13</volume>(<issue>1</issue>):<fpage>233</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2334-13-233</pub-id><pub-id pub-id-type="pmid">23701864</pub-id></mixed-citation></ref><ref id="R49"><label>49</label><mixed-citation publication-type="journal"><string-name><surname>Okoronkwo</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Okeke</surname>
<given-names>U</given-names></string-name>, <string-name><surname>Chinweuba</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Iheanacho</surname>
<given-names>P</given-names></string-name>. <article-title>Nonadherence factors and sociodemographic characteristics of HIV-infected adults receiving antiretroviral therapy in Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria.</article-title><source>ISRN AIDS</source>. <year>2013</year>;<volume>2013</volume>:<fpage>843794</fpage>. <pub-id pub-id-type="doi">10.1155/2013/843794</pub-id><pub-id pub-id-type="pmid">24369526</pub-id></mixed-citation></ref><ref id="R50"><label>50</label><mixed-citation publication-type="journal"><string-name><surname>Vissman</surname>
<given-names>AT</given-names></string-name>, <string-name><surname>Young</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Wilkin</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Rhodes</surname>
<given-names>SD</given-names></string-name>. <article-title>Correlates of HAART adherence among immigrant Latinos in the Southeastern United States.</article-title><source>AIDS Care</source>. <year>2013</year>;<volume>25</volume>(<issue>3</issue>):<fpage>356</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="pmid">22835082</pub-id></mixed-citation></ref><ref id="R51"><label>51</label><mixed-citation publication-type="journal"><string-name><surname>Tran</surname>
<given-names>BX</given-names></string-name>, <string-name><surname>Nguyen</surname>
<given-names>LT</given-names></string-name>, <string-name><surname>Nguyen</surname>
<given-names>NH</given-names></string-name>, <string-name><surname>Hoang</surname>
<given-names>QV</given-names></string-name>, <string-name><surname>Hwang</surname>
<given-names>J</given-names></string-name>. <article-title>Determinants of antiretroviral treatment adherence among HIV/AIDS patients: a multisite study.</article-title><source>Glob Health Action</source>. <year>2013</year>;<volume>6</volume>(<issue>0</issue>):<fpage>19570</fpage>. <pub-id pub-id-type="doi">10.3402/gha.v6i0.19570</pub-id><pub-id pub-id-type="pmid">23497956</pub-id></mixed-citation></ref><ref id="R52"><label>52</label><mixed-citation publication-type="journal"><string-name><surname>Saha</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Saha</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Sarkar</surname>
<given-names>AP</given-names></string-name>, <string-name><surname>Das</surname>
<given-names>DK</given-names></string-name>, <string-name><surname>Misra</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Bhattacharya</surname>
<given-names>K</given-names></string-name>, <etal>et al.</etal><article-title>Adherence to highly active antiretroviral therapy in a tertiary care hospital in West Bengal, India.</article-title><source>Singapore Med J</source>. <year>2014</year>;<volume>55</volume>(<issue>2</issue>):<fpage>92</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.11622/smedj.2014021</pub-id><pub-id pub-id-type="pmid">24570318</pub-id></mixed-citation></ref><ref id="R53"><label>53</label><mixed-citation publication-type="journal"><string-name><surname>Shigdel</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Klouman</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Bhandari</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ahmed</surname>
<given-names>LA</given-names></string-name>. <article-title>Factors associated with adherence to antiretroviral therapy in HIV-infected patients in Kathmandu District, Nepal.</article-title><source>HIV AIDS (Auckl)</source>. <year>2014</year>;<volume>6</volume>:<fpage>109</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.2147/HIV.S55816</pub-id><pub-id pub-id-type="pmid">25028564</pub-id></mixed-citation></ref><ref id="R54"><label>54</label><mixed-citation publication-type="journal"><string-name><surname>Johada</surname>
<given-names>M</given-names></string-name>. <article-title>Work, employment, and unemployment: values, theories, and approaches in social research.</article-title><source>Am Psychol</source>. <year>1981</year>;<volume>36</volume>(<issue>2</issue>):<fpage>184</fpage>&#x02013;<lpage>91</lpage>
<pub-id pub-id-type="doi">10.1037/0003-066X.36.2.184</pub-id></mixed-citation></ref><ref id="R55"><label>55</label><mixed-citation publication-type="journal"><string-name><surname>Sousa-Ribeiro</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Sverke</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Coimbra</surname>
<given-names>L</given-names></string-name>. <article-title>Perceived quality of the psychosocial environment and well-being in employed and unemployed older adults: the importance of latent benefits and environmental vitamins.</article-title><source>Econ Ind Democracy</source>. Epub 2014 Jul 26. <pub-id pub-id-type="doi">10.1177/0143831X13491840</pub-id></mixed-citation></ref><ref id="R56"><label>56</label><mixed-citation publication-type="journal"><string-name><surname>Murphy</surname>
<given-names>GC</given-names></string-name>, <string-name><surname>Athanasou</surname>
<given-names>JA</given-names></string-name>. <article-title>The effect of unemployment on mental health.</article-title><source>J Occup Organ Psychol</source>. <year>1999</year>;<volume>72</volume>(<issue>1</issue>):<fpage>83</fpage>&#x02013;<lpage>99</lpage>
<pub-id pub-id-type="doi">10.1348/096317999166518</pub-id></mixed-citation></ref><ref id="R57"><label>57</label><mixed-citation publication-type="journal"><string-name><surname>Gonzalez</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Batchelder</surname>
<given-names>AW</given-names></string-name>, <string-name><surname>Psaros</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Safren</surname>
<given-names>SA</given-names></string-name>. <article-title>Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis.</article-title><source>J Acquir Immune Defic Syndr</source>. <year>2011</year>;<volume>58</volume>(<issue>2</issue>):<fpage>181</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">21857529</pub-id></mixed-citation></ref><ref id="R58"><label>58</label><mixed-citation publication-type="journal"><string-name><surname>Milloy</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Kerr</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Bangsberg</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Buxton</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Parashar</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Guillemi</surname>
<given-names>S</given-names></string-name>, <etal>et al.</etal><article-title>Homelessness as a structural barrier to effective antiretroviral therapy among HIV-seropositive illicit drug users in a Canadian setting.</article-title><source>AIDS Patient Care STDS</source>. <year>2012</year>;<volume>26</volume>(<issue>1</issue>):<fpage>60</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1089/apc.2011.0169</pub-id><pub-id pub-id-type="pmid">22107040</pub-id></mixed-citation></ref><ref id="R59"><label>59</label><mixed-citation publication-type="journal"><string-name><surname>Young</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Wheeler</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>McCoy</surname>
<given-names>SI</given-names></string-name>, <string-name><surname>Weiser</surname>
<given-names>SD</given-names></string-name>. <article-title>A review of the role of food insecurity in adherence to care and treatment among adult and pediatric populations living with HIV and AIDS.</article-title><source>AIDS Behav</source>. <year>2014</year>;<volume>18</volume>(<issue>S5</issue>) <supplement>Suppl 5</supplement>:<fpage>505</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1007/s10461-013-0547-4</pub-id><pub-id pub-id-type="pmid">24469223</pub-id></mixed-citation></ref><ref id="R60"><label>60</label><mixed-citation publication-type="journal"><string-name><surname>Rueda</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Raboud</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Mustard</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Bayoumi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Lavis</surname>
<given-names>JN</given-names></string-name>, <string-name><surname>Rourke</surname>
<given-names>SB</given-names></string-name>. <article-title>Employment status is associated with both physical and mental health quality of life in people living with HIV.</article-title><source>AIDS Care</source>. <year>2011</year>;<volume>23</volume>(<issue>4</issue>):<fpage>435</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1080/09540121.2010.507952</pub-id><pub-id pub-id-type="pmid">21271396</pub-id></mixed-citation></ref><ref id="R61"><label>61</label><mixed-citation publication-type="journal"><string-name><surname>Rosen</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ketlhapile</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Sanne</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Desilva</surname>
<given-names>MB</given-names></string-name>. <article-title>Differences in normal activities, job performance and symptom prevalence between patients not yet on antiretroviral therapy and patients initiating therapy in South Africa.</article-title><source>AIDS</source>. <year>2008</year>;<volume>22</volume><issue>Suppl 1</issue>:<fpage>S131</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1097/01.aids.0000327634.92844.91</pub-id><pub-id pub-id-type="pmid">18664945</pub-id></mixed-citation></ref><ref id="R62"><label>62</label><mixed-citation publication-type="journal"><string-name><surname>Bor</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Tanser</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Newell</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>B&#x000e4;rnighausen</surname>
<given-names>T</given-names></string-name>. <article-title>In a study of a population cohort in South Africa, HIV patients on antiretrovirals had nearly full recovery of employment.</article-title><source>Health Aff (Millwood)</source>. <year>2012</year>;<volume>31</volume>(<issue>7</issue>):<fpage>1459</fpage>&#x02013;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1377/hlthaff.2012.0407</pub-id><pub-id pub-id-type="pmid">22778335</pub-id></mixed-citation></ref><ref id="R63"><label>63</label><mixed-citation publication-type="journal"><string-name><surname>Dahab</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kielmann</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Charalambous</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Karstaedt</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Hamilton</surname>
<given-names>R</given-names></string-name>, <string-name><surname>La Grange</surname>
<given-names>L</given-names></string-name>, <etal>et al.</etal><article-title>Contrasting reasons for discontinuation of antiretroviral therapy in workplace and public-sector HIV programs in South Africa.</article-title><source>AIDS Patient Care STDS</source>. <year>2011</year>;<volume>25</volume>(<issue>1</issue>):<fpage>53</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1089/apc.2010.0140</pub-id><pub-id pub-id-type="pmid">21214378</pub-id></mixed-citation></ref><ref id="R64"><label>64</label><mixed-citation publication-type="journal"><string-name><surname>Braitstein</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Boulle</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Nash</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Brinkhof</surname>
<given-names>MW</given-names></string-name>, <string-name><surname>Dabis</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Laurent</surname>
<given-names>C</given-names></string-name>, <etal>et al.</etal>; <collab>Antiretroviral Therapy in Lower Income Countries (ART-LINC) study group</collab>. <article-title>Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration.</article-title><source>J Womens Health (Larchmt)</source>. <year>2008</year>;<volume>17</volume>(<issue>1</issue>):<fpage>47</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1089/jwh.2007.0353</pub-id><pub-id pub-id-type="pmid">18240981</pub-id></mixed-citation></ref><ref id="R65"><label>65</label><mixed-citation publication-type="journal"><string-name><surname>Anema</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Vogenthaler</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Frongillo</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Kadiyala</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Weiser</surname>
<given-names>SD</given-names></string-name>. <article-title>Food insecurity and HIV/AIDS: current knowledge, gaps, and research priorities.</article-title><source>Curr HIV/AIDS Rep</source>. <year>2009</year>;<volume>6</volume>(<issue>4</issue>):<fpage>224</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1007/s11904-009-0030-z</pub-id><pub-id pub-id-type="pmid">19849966</pub-id></mixed-citation></ref><ref id="R66"><label>66</label><mixed-citation publication-type="journal"><string-name><surname>Puskas</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Forrest</surname>
<given-names>JI</given-names></string-name>, <string-name><surname>Parashar</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Salters</surname>
<given-names>KA</given-names></string-name>, <string-name><surname>Cescon</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Kaida</surname>
<given-names>A</given-names></string-name>, <etal>et al.</etal><article-title>Women and vulnerability to HAART non-adherence: a literature review of treatment adherence by gender from 2000 to 2011.</article-title><source>Curr HIV/AIDS Rep</source>. <year>2011</year>;<volume>8</volume>(<issue>4</issue>):<fpage>277</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1007/s11904-011-0098-0</pub-id><pub-id pub-id-type="pmid">21989672</pub-id></mixed-citation></ref><ref id="R67"><label>67</label><mixed-citation publication-type="journal"><string-name><surname>Nachega</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>Mugavero</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Zeier</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Vit&#x000f3;ria</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Gallant</surname>
<given-names>JE</given-names></string-name>. <article-title>Treatment simplification in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality of life and decrease healthcare costs.</article-title><source>Patient Prefer Adherence</source>. <year>2011</year>;<volume>5</volume>:<fpage>357</fpage>&#x02013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.2147/PPA.S22771</pub-id><pub-id pub-id-type="pmid">21845035</pub-id></mixed-citation></ref><ref id="R68"><label>68</label><mixed-citation publication-type="journal"><string-name><surname>Nachega</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>Parienti</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Uthman</surname>
<given-names>OA</given-names></string-name>, <string-name><surname>Gross</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Dowdy</surname>
<given-names>DW</given-names></string-name>, <string-name><surname>Sax</surname>
<given-names>PE</given-names></string-name>, <etal>et al.</etal><article-title>Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: a meta-analysis of randomized controlled trials.</article-title><source>Clin Infect Dis</source>. <year>2014</year>;<volume>58</volume>(<issue>9</issue>):<fpage>1297</fpage>&#x02013;<lpage>307</lpage>. <pub-id pub-id-type="doi">10.1093/cid/ciu046</pub-id><pub-id pub-id-type="pmid">24457345</pub-id></mixed-citation></ref><ref id="R69"><label>69</label><mixed-citation publication-type="journal"><string-name><surname>Ioannidis</surname>
<given-names>JP</given-names></string-name>, <string-name><surname>Patsopoulos</surname>
<given-names>NA</given-names></string-name>, <string-name><surname>Rothstein</surname>
<given-names>HR</given-names></string-name>. <article-title>Reasons or excuses for avoiding meta-analysis in forest plots.</article-title><source>BMJ</source>. <year>2008</year>;<volume>336</volume>(<issue>7658</issue>):<fpage>1413</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1136/bmj.a117</pub-id><pub-id pub-id-type="pmid">18566080</pub-id></mixed-citation></ref></ref-list></back></article>